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ABSTRACT
As a leading cause of death worldwide, coronary artery disease affects people of all races and
ethnicities. The foundation for the prevention of secondary fatal cardiac events, such as stroke
or myocardial infarction, is lifestyle modification to effectively lower cholesterol levels. Lifestyle
change impacts diet, physical activity, smoking habits, vital sign measures, and stress
management. The purpose of this evidence-based practice project was to reduce implement a
lifestyle intervention to lower LDL-C levels and promote healthier lifestyles. This practice change
was developed utilizing Stetler’s Research Utilization model to promote evidence-based practice
changes in the clinical setting. Nola Pender’s Health Promotion model was applied to facilitate
the implementation of the intervention. A systematic literature search revealed 16 pieces of
evidence that were used to develop a lifestyle modification program which entailed
individualized counseling and a patient-guided booklet to facilitate heart healthy lifestyle
changes. The created patient-guided booklet contains material from this literature as well as the
American Heart Association and the National Institute of Health. A total of 14 adult participants
were recruited from a local cardiology practice and were evaluated at their initial evaluation and
then again 6 months later. The primary outcome measurement was the low- density lipoprotein
cholesterol (LDL-C) drawn from a fasting lipid panel; secondary outcomes measured were blood
pressure, body mass index, dietary habits, and physical activity patterns. Paired t-tests were run
with a significance level set at p <.05. Significant outcomes that were found include dietary
habits (p =.011) and physical activity patterns (p =.031). There was no significant change in
LDL-C levels pre- and post- intervention (p =.461). The results of this evidence-based practice
project will be used to implement a cost-effective, patient-centered strategy in the clinical setting
to lower a patient’s risk for a secondary cardiac event by changing lifestyle choices.
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CHAPTER 1
INTRODUCTION
Background
Each year cardiovascular disease is the leading cause of mortality in the world with 17.7
million deaths globally and 610,000 deaths in the United States (WHO, 2018; CDC, 2017).
Cardiovascular disease encompasses a variety of diseases that affect the heart and peripheral
vascular structures, such as hypertension, atrial fibrillation, coronary artery disease, heart
failure, and stroke (AHA/ASA, 2017). Coronary artery disease (CAD) is the most prevalent
cause of heart disease contributing to 366,000 deaths in 2015 and 28.1 million people
diagnosed in 2016 (CDC, 2017); 11.5% of adults in the U. S. live with CAD. Risk factors for
developing CAD include lifestyle choices, family history, high cholesterol (hyperlipidemia), high
blood pressure (hypertension), and cigarette smoking (CDC, 2015). Other risk factors consist of
metabolic syndrome, diabetes mellitus Type II, obesity, dyslipidemia, sedentary lifestyle, and
sleep disorders (Roever, Biondi- Zoccai, & Rao, 2017). Hyperlipidemia is the major modifiable
risk factor for the development of heart disease that can be managed with lifestyle interventions
and medications. Several task forces are working to lower the incidence of cardiovascular
disease through primary and secondary prevention. One of the objectives for the Healthy
People 2020 initiative is to “improve cardiovascular health and quality of life through prevention,
detection, and treatment of risk factors for heart attack and stroke” (Healthy People 2020, 2018).
Statement of the Problem
The American College of Cardiology and the American Heart Association (ACC/AHA)
2018 national guidelines on the treatment of hyperlipidemia incorporate both pharmacological
and nonpharmacological approaches to reduce patients’ risk for primary and secondary fatal
cardiac events. A fatal cardiac event is the occurrence of stroke, heart attack, or death. These
guidelines stress the importance of “lifestyle as the foundation for ASCVD risk-reduction”
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(ACC/AHA, 2014, p. 2895). Atherosclerotic cardiovascular disease (ASCVD) 10-year risk
calculator determines the overall risk of heart disease and stroke over a ten-year period and is
used frequently in the primary and specialty office settings to determine a patient’s cardiac risk
for those patients who have not had a fatal event or prior diagnosis of CAD (ACC, 2018). Not all
providers discuss the important benefits of making healthy lifestyle choices and maintaining that
lifestyle. If adult patients with CAD are not only prescribed statin-therapy but also given dietary
advice regarding national recommendations for a heart healthy diet and adequate physical
activity, there would be decreased hospitalizations and fatal cardiac events, prolonging the
longevity and quality of life in this population.
Hyperlipidemia in adult patients with CAD increases the risk for fatal cardiac events
which include heart attack, stroke, or death. As a modifiable risk factor, treatment for
hyperlipidemia involves pharmacological and nonpharmacological therapies. Pharmacological
therapies include statin therapy as first-line treatment options in conjunction with lifestyle
modifications such as dietary changes, physical activity, stress management, and weight
management (AHA, 2017). The overall aim of these therapies is to decrease the low-density
lipoprotein cholesterol (LDL-C). Unfortunately, there is difficulty achieving this treatment goals
and lifestyle modifications in the clinical setting. The need for a lifestyle change intervention
regarding dietary changes and physical activity is evident throughout the literature.
Data from the Literature Supporting Need for the Project
According to Cardoso, Moraes, Rosa, & Moreira (2015) only 14% of patients actively
follow guideline recommendations. As the leading cause of death worldwide and across the
nation, the United States Preventive Services Task Force (USPSTF) (2014) encourages
providers to prevent the occurrence of hyperlipidemia in overweight or obese patients with
“intensive behavioral counseling interventions to promote a healthful diet and physical activity
for cardiovascular (CVD) prevention”. This guideline is given a grade B as a recommended
practice.
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According to Heaton & Frede, 2006, Voogdt-Pruis, Van Ree, Gorgels, & Beusmans, 2011,
healthcare providers have fallen short due to time and resource constraints. HealthyPeople
2020 released objectives with solutions to reduce the number of deaths from coronary artery
disease (from 129.2 per 100,00 people in 2007 down to 103.4 per 100,000 in 2020) and reduce
the overall number of adults with high cholesterol (from 15.0 per 100,000 down to 13.5 per
100,000 in 2020) by adhering to heart healthy diets and incorporating physical activity
(HealthyPeople, 2014). In addition to lifestyle factors, patients with established CAD should be
prescribed statin therapy for treatment and protection.
As a worldwide epidemic, coronary disease is monitored by global task forces to reduce
incidence and monitor prevalence. A cross-sectional study that surveyed twenty-four European
countries (EUROASPIRE IV) showed providers are still lacking application of lifestyle
modification recommendations for the secondary prevention of cardiac events. Even in those
patients taking lipid lowering agents alone, medication needs the support of healthy lifestyle
changes (Kotseva et al., 2016). In addition, a retrospective, randomized control trial study
analyzed the factors influencing physician counseling on cardiovascular risk. The results
revealed, regardless of blood pressure readings and lab results, overt signs of obesity,
appearance and weight, were the driving factor for lifestyle counseling (Rakita, Homko,
Kashem, Memon, & Bove, 2016). Therefore, not all patients received adequate counseling
regarding lifestyle modifications to reduce the risk or burden of coronary disease. With the many
tools available from the AHA, providers are not taking advantage of using them during follow up
visits (AHA, 2018).
Data from the Clinical Agency Supporting Need for the Project
CAD is not just prevalent world and nationwide, but also significant locally as the CDC
reports numbers in comparison to the national average. In Lake County, Indiana, there were
190.4 deaths per 100,000 people ages 35 and older from 2013-2015, which compares to the
national average of 194.5 deaths per 100,000 people (CDC, 2018). A local cardiology practice
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that serves the population of Lake County, Indiana, and is a part of a larger, non-profit
healthcare system sees approximately 78 patients per week with a variety of patients with
cardiovascular diseases. The struggle of managing patients with multiple comorbidities has
become overwhelming to healthcare providers. Providers focus on emergent issues at follow-up
visits, and time is not always spent counseling on preventive care. According to the 2013
ACC/AHA guidelines on the treatment of blood cholesterol and lifestyle counseling, modification
should precede and work in conjunction with pharmacological therapies to lower LDL-C levels.
Although current recommendations do not set a specific LDL-C target goal, the cardiologist
prefers 50% of baseline or less than 70 mg/dL. Patients with CAD are also prescribed statin
therapy for treatment, and in some cases, patients are even referred to a dietician. The
cardiologist at this clinical site provides usual care in accordance with national guidelines and
patient preferences to enforce secondary prevention in CAD. Due to time constraints and lack of
meaningful resources, lifestyle counseling is not always provided during local office visits for
CAD patients struggling with hyperlipidemia.
The healthcare providers at this site would like to incorporate the patient in shareddecision making and mutual goal setting to promote healthy lifestyle habits. The healthcare
providers at this site agree nonpharmacological approaches to meet clinical guidelines need to
be a priority in patient care and welcome the opportunity to improve upon their current practice.
The application of evidence-based practice (EBP) in this particular clinical setting meets the
national recommendation guidelines and priorities of these healthcare providers. Also, there is a
lack of resources at this clinical site to discuss these changes with patients, hindering the
opportunity to outline major lifestyle contributors and guide the patient to healthier lifestyle
behaviors. This project counseled and supplied patients with the necessary materials from the
AHA and NIH to promote self-managing behaviors to lower LDL-C levels and the overall risk for
a fatal or nonfatal cardiac event.

LIFESTYLE MODIFICATION PROGRAM

5

Purpose of the Evidence-Based Practice Project
The impact of lifestyle behaviors is evident by the lack of lipoprotein control and
evidence of fatal or non-fatal CAD events. The purpose of this EBP project is to implement a
lifestyle intervention to lower LDL cholesterol and promote healthier lifestyles. Participants were
counseled on lifestyle modifications, after assessing their current lifestyle choices, using
materials emphasized in the national guidelines. The focus of this counseling was to target
lower LDL cholesterol levels below 70mg for high-risk and less than 100 mg for low/moderate
risk adult patients with CAD in a way that is effective and time-efficient. Focusing on lowering
these cholesterol levels by targeting lifestyle modifications lowered cardiovascular risk, thus
reducing patient’s risk for a major cardiac event. Secondary outcomes included measuring
effects on blood pressure, body mass index (BMI), and dietary and physical activity changes.
Compelling Clinical Question
The compelling question that was answered over the length of this project was focused
on the effectiveness of a lifestyle intervention that aids in pharmacological therapy (if applicable)
to improve cholesterol levels in adults with coronary heart disease. Although there are various
diets available for patients to follow, the ACC/AHA (2013) recommends a “heart healthy diet” for
lowering adult LDL-C. A heart healthy diet consists of decreasing dietary fat (especially
saturated and trans fat) intake and increasing intake of vegetables, fruits, and whole grains
(Eckel et al., 2014). Other important foods to incorporate into a heart healthy diet are low-fat
dairy products, poultry, fish, legumes, non-tropical vegetable oils, and nuts. Necessary
eliminations include refined sugars, which are found in most bakery items and beverages, and
red meat, from beef and lamb. These changes will be made through following the DASH dietary
plan (Dietary Approach to Stop Hypertension).
In addition to dietary recommendations, physical activity is another crucial component to
reaching lower LDL-C levels. Eckel et al. (2014) advises adults to participate in 40-minute
moderate-to-high intensity aerobic exercise 3-4 times per week. As a result, Eckel et al. (2014)
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estimated that 6% of CAD could be eliminated worldwide with life expectancy to increase by
0.68 years with the incorporation of physical activity. Patients also take lipid-lowering
medications which help maintain therapeutic LDL-C levels. Statin therapy, which is a first line
therapy for lipid reduction, varies by intensity, based on patient’s cardiovascular risk and
medical history; high-intensity statin therapy should be prescribed for patients less than 75
years of age who have CAD (Stone et al., 2014). Lifestyle modifications (diet and physical
activity) and lipid-lowering medial therapy complement one another to achieve optimal results.
Will there be clinical significance to focus more on health-promoting behaviors as the guidelines
and current literatures insists?
PICOT Question
The PICOT clinical question that was evaluated is: in adult patients with CAD, does
dietary and physical activity counseling with a lifestyle intervention lower cholesterol levels in six
months?
Significance of the EBP Project
With the projected increase of cardiovascular diseases, the AHA/ASA (2017) predicts by
the year 2035, half of the United States population will have some form of cardiovascular
disease. This disease costs healthcare systems a significant amount of money and time when
caring for these patients. In 2016, cardiovascular disease cost the nation $555 billion and is
projected to drastically increase to $1.1 trillion by the year 2035 (ACC/ASA, 2017). More
specifically, CAD contributes $89 billion to these medical costs, making it the most expensive of
the cardiovascular diseases. Considering the cost of CAD, actions must be taken to reduce the
burden through primary and secondary prevention.
The overall significance of this project will be to apply EBP in a meaningful way that
impacts local practice to adopt a useful clinical lifestyle intervention. Targeted outcomes
included lower LDL-C levels, therapeutic blood pressure, weight loss and maintenance,
improvement in dietary choices, and physical activity adherence. These outcomes were
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measured with fasting serum lipid panel, blood pressure readings from office
sphygmomanometer, BMI calculations, Rate-Your-Plate for Blood Cholesterol Tool, and The
Rapid Assessment of Physical Activity Tool. After the implementation and evaluation of this EBP
project, patients were empowered to possess better self-management skills over their disease
and implement ways to improve their cardiac health. The providers are able to utilize a
resource, that is time efficient and cost-effective, yet patient-centered, in the clinical setting;
thus, preventing any long-term effects for CAD patients with hyperlipidemia. Ultimately, this
improves quality of services, cost of implementation, and access to a lifestyle intervention.

CHAPTER 2
THEORETICAL FRAMEWORK, EBP MODEL, AND REVIEW OF LITERATURE
Theoretical Framework
Overview of Nola Pender’s Health Promotion Model
As a nursing theory in the context of health promotion, Nola Pender’s Health Promotion
Model (HPM) will be applied to this EBP project. Based on self-regulatory and self-reflective
concepts from Bandura’s Social Cognitive Theory, Pender’s first draft was published in 1982
with several revisions since then (George, 2011; Pender, Murdaugh, & Parsons, 2015). The
nursing metaparadigm consists of the four concepts: the patient, health, environment, and
nurse; this concept is essential and evident in Pender’s work. The definition of health varies per
patient as either absence of disease, optimal functioning, or a more abstract definition that
changes over time. Determinants of health include age, socioeconomic elements, culture, and
environment, which are inseparable from other life situations (Pender et al., 2015).
Three assumptions of the HPM are: the patient seeks help from the healthcare provider
to reach optimal levels of health, has the ability to reflect on past experiences and make rational
decisions regarding future decisions, and patients must have the desire for positive health
experiences that produce healthy outcomes. Patients must possess self-regulation over lifestyle
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Healthcare providers have a significant role in the environment that helps facilitate change, but
the patient must initiate health-related changes as a result of interaction with the environment,
which is essential to behavior change (George, 2011). The concept of health promotion and
behavior change are the overarching concepts of this model, but there are several minor
concepts also developed in this framework. These major concepts include: a) individual
characteristics and experiences (prior related behavior and personal factors), b) behaviorspecific cognitions and affect (perceived benefits of action, perceived barriers to action,
perceived self-efficacy, activity-related affect, interpersonal influences, situational influences,
commitment to a plan of action, and immediate competing demands and preferences), and c)
behavioral outcome (health promoting behavior) (Pender et al., 2015).
The major concept of individual characteristics and experiences that influence health
behaviors. These minor concepts that stem from individual characteristics and experiences are
prior-related behaviors and personal factors. A patient’s prior-related behaviors predict future
behaviors and decisions; perceived benefits influence the likelihood of a behavior being
repeated, thus being able to predict outcomes while considering barriers of prior-related
behaviors (Pender et al., 2015). The nurse’s essential role “helps individuals shape a positive
behavioral history for the future by focusing on the benefits of a behavior, teaching how to
overcome hurdles to performing the behavior, and building high levels of efficacy and positive
affect through successful performance experience and feedback” (Pender et al., 2015, p. 36).
Personal factors help predict behavioral actions based on biological factors (age, sex,
BMI, and family and medical history), psychological (current self-esteem, motivation, and
perception, and socioeconomical (race, culture, education, and socioeconomic status) (Pender
et al., 2015). These factors promote the incorporation of the nursing metaparadigm and are
individualized per patient that impact current state of health. They need to be analyzed and
incorporated into the intervention as means to fulfill patient’s commitment to action plan.

8
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The essential core concept of behavior specific cognitions and affect influences the
health-promoting intervention and must be measured to determine if the specific intervention
caused the behavioral change. Following the minor concepts include perceived benefits of
action, perceived barriers to action, perceived self-efficacy, activity-related affect, interpersonal
influences, situational influences, commitment to a plan of action, and immediate competing
demands and preferences. The perceived benefits of action should focus on the positive
aspects of health-promoting behavior, because beliefs in positive outcomes, leads to better
outcomes (Pender et al., 2015). If the patient perceives they can perform a health-promoting
behavior, they will be motivated toward self-efficacy through intrinsic and extrinsic benefits
which creates more awareness.
Perceived barriers to action are “viewed as mental blocks, hurdles, and personal costs of
undertaking a given behavior” that need to be addressed as soon as possible to revise the
action plan (Pender et al., 2015, p. 37). These barriers may include cost, time, transportation, or
stress. It is essential to discuss barriers to form an action plan that accommodates the patient to
overcome potential barriers to action. A big component of the HPM is the patient’s ability to
comprehend and initiate health-promoting behaviors. Perceived self-efficacy consists of
judgement of skill and critical thinking to plan for certain outcomes and can increase patient’s
motivation to participate in a particular skill in which they excel (Pender et al., 2015). This
concept increases the benefit of the action and is encouraging to the patient, as it increases
positive thoughts of confidence and competency. Increased perception of self-efficacy motivates
the patient directly by intensifying the affects to pursue a commitment to plan of action.
The activity-related affect consists of the emotional response to a health-promoting
intervention, which is dependent upon self-acting and the environment (Pender et al., 2015).
How the patient feels after completing a health-promoting behavior determines whether or not
the action will be repeated or continued in the future. As previously stated, emotions and
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feelings happen prior, during, and following an intervention, and if the response is positive, the
behavior will most likely be repeated.
Interpersonal influences consist of the thoughts and actions of others. These influences
originate from family, friends, peers, coworkers, and healthcare providers (Pender et al., 2015).
Other thoughts about one’s health and opinion over perceived benefits impact patient’s
expectations and behaviors; some influences come from social expectations and norms, peer
pressure, social support, and modeling behavior from others. These influences may result in
either pressure or encouragement to participate in health promoting behaviors.
Situational influences are factors from the available options, details of the healthpromoting intervention, and environmental factors. Patients are more comfortable and
competent in environments in which they feel “compatible, related, and safe and reassured”
(Pender et al., 2015, p. 38). This concept provides insight to providing patient-centered care..
Situational influences must be re-evaluated throughout the implementation phase for
maintenance in each patient’s unique, individual characteristics and experiences.
The commitment to a plan of action is the initiation of the patient to engage in the healthpromoting intervention, unless there are competing demands that affect participation (Pender et
al., 2015). Patients are more willing to participate in organized rather than unorganized,
unplanned lifestyle change behaviors. Two underlying assumptions of cognitive processes are
the implementation intention with a given time and place, either alone or with support and
defining concrete strategies for initiating and performing health promoting behaviors. There
must be a mutual agreement between the healthcare provider and patient to set a plan of action
and strategy to motivate and “reinforce health behaviors according to individual preferences”
(Pender et al., 2015, p. 39). This agreement brings the patient to a realization of the critical
health behavior change and establishes a commitment to follow through with the behavior due
to interpersonal influence.
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Immediate competing demands and preferences are types of demands and preferences
that distract or take precedent over the initiation or maintenance of health-promoting behavior
(Pender et al., 2015). Patient usually have little or no control over these feelings, they are not to
be confused with barriers. Competing demands and preferences occur in the moment. This
concept is evident by the patient’s behavior changes in relation to the health promoting behavior
and desirable health goals. Health promoting behavior is the finish line or end point of the HPM.
Ending at this point prepares the patient for continual maintenance of behavior which improves
overall health status, quality of life, and functioning (Pender et al., 2015). At this point, the
patient has established health-promoting behavior and may even influence others through
modeling and feedback to influence them to also achieve this endpoint of self-efficacy over
health behaviors. This concept is the overall goal and requires continual maintenance with
feedback from the provider.
Application of Theoretical Framework to EBP Project
The application of Pender’s HPM is appropriate for the context of this EBP project and
measurable outcomes in clinical practice. Since the basis of lowering LDL-C levels is based on
the health-promoting behaviors of making heart healthy decision in regards to food consumption
and incorporating physical activity into sedentary lifestyle, the concepts of the HPM are
applicable to patients seen in this outpatient cardiology clinical office. According to Pender et al.
(2015) strategies to impact behavior change would involve raising awareness of CAD and fatal
events, re-evaluation of self, setting goals that focus on shared-decision making with patient,
promoting self-efficacy to guide the patient toward health promoting behaviors, enhance the
benefits of change by achieving baseline LDL-C levels to show the magnitude of progress,
recognizing cues to promote change, and managing barriers to change.
Understanding a patient’s perception of self-efficacy influences the patient’s ability to
participate in a lifestyle modification treatment plan. If they perceive they cannot do it based on
their previous attempts and inept skills, then chances are they have low self-efficacy and may
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need reassurance on their current abilities and where to start. Prior poor dietary and physical
activity habits lead to undesirable health outcomes and the progressive advancement of CAD.
The project manager’s role was to assess previous dietary choices and sedentary lifestyle that
contributed to the poor control over LDL-C level to anticipate the patient’s future behaviors.
The participants of this EBP project were encouraged to focus on their positive intrinsic
and extrinsic factors to strengthen their self-efficacy. Intrinsic factors will vary per participant and
will be highlighted during the counseling portion of the intervention. These factors may include
the way the participant feels about making health-conscious decisions regarding diet and
physical activity. Extrinsic factors will focus on possible positive rewards or outcomes the patient
perceives from participating in this EBP project. This process of evaluating intrinsic and extrinsic
factors consider patient’s age, abilities, current mood or thought process, dietary preferences,
financial budget, career, and level of education. Patients may have certain preferences based
on their daily routine and what they are used to. One of the objectives of this project is to
provide patients with opportunities to make shopping decisions based on comfort level, starting
one small goal at a time and introducing physical activity into sedentary lifestyles with short
intervals at a time.
Competing demands is an important concept to consider when administering the
intervention. A patient may be driving home from the grocery store and instead of waiting and
cooking a heart healthy meal at home, decides to drive through a fast food chain due to the
immediate preference for fast food. These types of demands and preferences impede patient’s
ultimate intentions. Some patients may be more distracted than others. The process to
overcoming these competing demands and preferences requires training and exercising selfregulating and controlling behaviors. The behavioral outcome consists of the overall health
promoting behavior, which is the ultimate purpose of this nursing model.
After evaluating perceived benefits, overcoming barriers, evaluating situational and
interpersonal influences, and increasing self-efficacy, the patient will be able to possess better
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self-management with CAD. Tailoring individualized health-promoting behaviors through dietary
and physical activity counseling emphasizes patient preferences and provides patient-centered
care to prolong health maintenance.
Strengths and Limitations of Theoretical Framework for EBP Project
Although the HPM is successfully used in the context of health behavior change, it also
has theoretical and contextual limitations. One strength of the HPM is the applicability to desired
intervention in relation to intended outcomes of this EBP project. Adult patients living with CAD
and hyperlipidemia need a health promoting process to describe and explain the variables of
their behaviors and how to achieve optimal LDL-C levels. Due to the holistic, individualized
treatment plan needed to facilitate change for patients, the HPM provides guidance for
healthcare providers to be a change agent and predict behaviors of the individuals. On the other
hand, the HPM contains abstract concepts that are individualized to each patient and are hard,
if impossible, to measure when evaluating for adherence, perception, or efficacy. Also, the large
number of concepts within the model may be time-consuming, as this is a time efficient
counseling intervention. Another limitation is the modality of effectively communicating healthpromoting behaviors, as some patients may not want to change. The HPM allows the project
manager to discuss the various concepts with the patient to set goals and provide guidance for
overcoming barriers and competing demands or preferences to maintain a healthy lifestyle and
reduce cardiovascular risk.
Evidence-based Practice Model
The model used for this EBP process was Stetler’s model for Research Utilization.
The core of this model is critical thinking and systematic research utilization into EBP.
Overview of the Stetler Model
Nursing theory and nursing models of EBP are essential to achieve supportable
outcomes in EBP projects. The Stetler model for Research Utilization (Stetler model) is used to
guide the EBP process from establishing the clinical problem to evaluating clinical outcomes.
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The Stetler model’s primary focus is to use the synthesized research findings to implement a
clinical practice change; this process happens in five phases: the preparation phase (phase I),
the validation phase (phase II), the comparative evaluation and decision-making phase (phase
III), translation (phase IV), and evaluation (phase V) (Stetler, 2001). These phases are based on
the assumptions that each type of evidence is supported for use in the appropriate setting,
synthesized, translated, and then, evaluated for use “in a manner that is replicable, observable,
credible, verifiable, or basically supportable for safe and effective use” (Dang et al., 2015, p.
279).
It can also be used by novice to expert practitioners in everyday practice to improve
upon patient outcomes. Due to the applicability of the model to the clinical problem, this
particular EBP model was selected based on the previous revision of the Stetler model that
included external and internal bodies of evidence. The use external evidence is crucial due to
the emphasis on the ACC/AHA’s clinical guidelines for hyperlipidemia in CAD; this expert
consensus is widely used in healthcare settings and is the basis for most clinical decisions
(Melynk & Fineout-Overholt, 2015). Internal evidence is the information obtained from the
clinical site to establish a clinical problem and use the information from patients and healthcare
providers to support the clinical problem during the preparation phase. All the way through the
evaluation phase, the Stetler model is a comprehensive and systematic process that is
applicable to this EBP project for adult patients with CAD and hyperlipidemia.
Application of the Stetler Model to EBP Project
In the preparation phase, the observed clinical problem was that providers were
following the ACC/AHA clinical guidelines for hyperlipidemia, but not including all aspects of the
guidelines. As current practice outcomes have shown, cholesterol screening results have not
been optimal for patients with CAD. This problem is affirmed through actual observation that
occurred in the clinical setting and is evidenced by the lack of adherence and less than optimal
LDL-C results. Validation (phase II) was achieved after a thorough review of the current
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ACC/AHA national guidelines and a literature search through several databases; these
searches affirmed the significance of the clinical problem. After validating that hyperlipidemia
and poor lifestyle choices are a prevalent clinical problem in patients with CAD, the synthesis of
the literature supported the need for a more individualized treatment plan for these patients. The
decision to use the findings of the literature search was based on synthesis of the data collected
to support the basis of this EBP project. The resources were selected based upon their
appraisal, the level and quality. As a result, the next stage of the process was to transition into
the translation/application phase to address the need for a lifestyle intervention.
To translate the synthesis of the literature into a relatable practice, a change in current
practice involved a shared-decision making and patient-guided tool. A synthesis of the literature
summarized the EBP findings and allowed patients to be more self-led through this process by
encouraging goal-setting and providing resources that support these changes. This approach
was instrumental to the longevity of health-promoting behaviors. Methods to implement this
change included formal heart healthy lifestyle counseling and distribution of an interactive
patient-guided tool. The application of this type of interaction promotes self-efficacy to manage
the disease long-term, which the literature supports as a present problem. The goals of
implementing this EBP project were to evaluate a patient-centered, time-efficient, and costeffective tool to guide patients toward healthier behaviors that can be used in an outpatient
cardiology clinical setting. The overall evaluation was the collection of serum LDL-C levels,
blood pressures, and calculating BMIs at the conclusion of the implementation period to
compare with the pre-intervention values. Therefore, the focus of applying health-promoting
behaviors based on EBP was crucial to the success of research utilization within this model.
Strengths and Limitations of the Stetler Model for EBP Project
The Stetler Model is widely accepted and used in nursing research as a means to
change health practices. Strengths of this model are the applicability to developing a plan of
action for EBP projects. Also, the systematic flow of the model allows for a step-by-step
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evaluation of the overall plan and goals for an EBP project. It can be used in formal and informal
ways, either in direct patient contact through an organization or in everyday clinical practice by a
practitioner. The information obtained from an EBP project can improve current practice. The
Stetler model is very complex and has several critical assumptions of the model which may or
may not be applicable to all users. The use of the model in an informal manner may be too
subjective and reduce the credibility to other nurse researchers; the lack of knowledge or novice
of one user may be using the model in an inappropriate manner. However, the Stetler model
was first published in 1976 and has since upheld its applicability of research findings into EBP
(Dang et al., 2015).
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Literature Search
To collect the evidence for best practice for CAD patients with hyperlipidemia, a
thorough literature search was conducted. Several databases were searched, and keywords
were used in the format of the PICOT question and narrowed down based upon MeSH and
CINAHL headings. After the best evidence was collected, a level organization and appraisal of
the evidence was conducted from Melynk and Fineout-Overholt (2015) for the leveling of
evidence and the Johns Hopkins Nursing Research/Non-Research Evidence Appraisal tool for
evidence appraisal (Dearholt & Dang, 2014). See Appendix A for complete literary synthesis.
Sources Examined for Relevant Evidence
In a search for the best available resources, the evidence was searched for in the
Joanna Briggs Institute (JBI), Cochrane, National Guideline Clearinghouse, Medline, and
CINAHL databases. Keywords of the PICOT question were used in the foundation for the initial
key searches. In the Medline and CINAHL databases, subject headings were utilized to
eliminate all possible variations of keyword usage in each of the two databases. Inclusion
criteria for final review was based on targeted population, intervention, outcomes measured,
English language, less than five years old, and country (similar to the cultures of the United
States). Studies were excluded if they were published in any language other than English, older
than five years, or did not fit the targeted population, intervention, or outcomes. The final search
resulted in a total of 747 articles from the included databases. Appendix A includes a complete
literary search and synthesis. Table 1.1 outlines the final results of the literature search.
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Table 1.1
Review of the Literature Table
Database

Results

Duplicates

Reviewed

Accepted

JBI

153

2

10

3

Cochrane

125

2

4

2

NGCH

173

1

3

1

Medline

102

2

18

9

CINAHL

194

2

6

1

Total

747

9

41

16
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The National Guideline Clearinghouse was searched for widely accepted clinical
guidelines. The keyword “cardiovascular disease” was used to find the protocol guidelines for
adult patients with CAD. Limiters in this database were U.S.-based organizations and years
from 2013-2017. This timeframe was selected to provide the most recent application of EBP. A
total of 173 guidelines were found with one duplicate and three were reviewed for consideration.
One widely accepted and used guidelines in clinical practice was used for evidentiary support
for CAD patients with hyperlipidemia. The other guidelines were based from medical programs
that applied this national guideline in their protocols for hyperlipidemia and CAD.
Then, a search was conducted in the JBI database to find evidence summaries
consisting of systematic reviews. The best search in the JBI database included of the main
concepts from the PICOT question, “cardiovascular disease” OR “coronary artery disease” AND
prevention, and the inclusion criteria listed. A total of 153 results, two were duplicates from other
databases. Ten results were considered for final review. Two of the three accepted systematic
reviews originated from an evidence based summary by Huong Nguyen (2017). The third
systematic review was citation chased from a JBI evidence summary from Fong (2016).
Furthermore, the Cochrane database of systematic reviews was searched using the keywords
“cardiovascular disease” OR “coronary artery disease” AND prevention. Date limiters were
applied to years 2013-2018, and reviews were eliminated from consideration if they did not meet
the PICOT criteria. The final search yielded 125 systematic reviews, two were duplicates in
other databases. A total of 4 reviews were considered for final review and two were accepted
into the best practice model.
The Medline and CINAHL databases were searched for the best supportive evidence.
MeSH headings were used in Medline to include widely used synonyms and eliminate any
variations in the keywords. The keywords used were MM “cardiovascular diseases” OR MM
“coronary disease” AND diet* OR nutrition OR lifestyle AND cholesterol OR lipid* OR
hyperlipidemia AND “physical activity” OR exercise AND MW “risk reduction behavior” OR MW

LIFESTYLE MODIFICATION PROGRAM

20

“secondary prevention”. These keywords were used as a result of analyzing the subject
headings for the included evidence to keep the search consistent. Exclusion criteria included
date limiters of years 2013-2018 and the English language. This search produced 102 results,
two which were duplicates found in the other databases, six were considered for final review.
Nine were accepted to support this project. The CINAHL database was searched using subject
headings to continue a systematic search. The words MM “cardiovascular diseases” OR MM
“coronary disease” AND diet* OR nutrition OR lifestyle OR physical activity OR exercise AND
cholesterol OR lipid* OR hyperlipidemia AND “behavior modification” OR prevention, also using
subject headings in the final search with English language, years 2013-2018, and scholarly
(peer-reviewed) journals as limiters. This search had 194 results with two duplicates included in
the other databases; six were included for the final review and one was accepted for synthesis
into EBP. This final search concluded all relevant evidence related to the topic of CAD patients
with hyperlipidemia and best practice to support a lifestyle intervention in EBP.
A total of 747 results were included and forty-one abstracts were reviewed. Duplicates
were excluded from review. During the examination process, each abstract was analyzed to
determine if they met criteria for this EBP project. Criteria for this EBP project was based on the
targeted population of adults with CAD, struggling with hyperlipidemia; studies were excluded if
they targeted CAD patients that had severe chronic disease, i.e. chronic kidney disease, HIV,
heart failure, etc., and studies that included pregnant women and children were excluded
because of their lack of connection to the targeted population. Due to the widespread
prevalence of this disease and its risk factors across the world, patients with diabetes mellitus II
were considered due to the heavy correlation between type II diabetes mellitus and CAD.
Primary prevention is a crucial component to preventing CAD; these studies were used for
application as a protective measure in secondary prevention. Then, studies were reviewed
based on their relevance to the intended intervention and measurable outcomes.
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Appraisal of Relevant Evidence
A critical appraisal was performed to evaluate the quality of the evidence for validity and
reliability. To determine the quality of the evidence used to support this EBP project,
the Johns Hopkins Research and Nonresearch Evidence Appraisal Tool was used to guide the
appraisal process (Dearholt & Dang, 2014). Studies were appraised not only based on
relevancy to the PICOT question, but also based on the quality of the study. The evidence
needed to have a clear purpose statement with goals that defined outcomes appropriate to care
for patients with CAD and hyperlipidemia. These goals included measurable outcomes or
descriptive pertinence to patients with CAD. Also, systematic reviews and RCTs needed to have
a current literature reviews. Systematic reviews contained reproducible search strategies that
covered more than one database and contained a diagram of eliminated studies but did not
appraise the strength of evidence or describe the quality of the studies used. Study details and
synthesized findings needed to be clear and relatable to patient population and outcomes
measured. Conclusions were gathered based on the results that were applicable to an
improvement of health-behavior interventions.
Ratings were given based on the outcomes of the appraisal questions. High quality (A)
ratings were given to those reviews and studies that showed purposeful results, sufficient
sample sizes, definitive conclusions, and consistent recommendations that related to the
outcomes of this project. Good quality ratings (B) were assigned to those with sufficient sample
sizes, some control over intervention, and recommendations were based on a mainly
comprehensive literature review. Low quality (C) ratings were flawed studies or reviews that had
inconsistent and unclear results, small sample sizes. The supportive evidence consisted of 9
As, 5 Bs, and 1 C quality rating, collectively displayed in Table 1.2. After the evidence was
collected, organized, and appraised, the data from the included literature search was
synthesized and translated into a best practice model to establish the best way to counsel
patients with CAD and hyperlipidemia.
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Table 1.2
Evidence Type and Appraisal
Level

Included

Quality

Design

Systematic Review of randomized
I

4

A (3)
controlled trials (4)
B (1)

II

1

III

2

A (1)

Randomized Control Trial (1)

A (1)
Quasi-Experimental (2)
B (1)
IV

1

V

2

VI

1

A (1)

Prospective Cohort Study (1)

B (1)

Systematic Review of descriptive studies

C (1)

(2)

A (1)

Cross Sectional Study (1)
Expert Panel (2)

A (2)
VII

4

Expert Opinion (1)
B (2)
Literature Review (1)
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Levels of Evidence
To determine the level of evidence, Melynk and Fineout-Overholt’s (2015) Rating
System for the Hierarchy of Evidence for Intervention/Treatment Questions was used for the
literature appraisal. This rating system was used based on the inclusion of keywords from the
PICOT question and a broader range of levels of evidence to include well-designed case control
and qualitative studies (Melynk & Fineout-Overholt, 2015). This hierarchy determines the ratings
from Level I to Level VII. Level I consists of evidence from systematic reviews and metaanalysis of all RCTs. Level II studies consist of well-designed RCTs. Level III is well-designed
controlled trials without the randomization of subjects. Level IV is evidence from well-designed
case-control and cohort studies. Level V includes evidence from systematic reviews that review
descriptive and qualitative studies. Level VI consists of evidence from single descriptive or
qualitative studies, and level VII is the expert opinions and/or reports of expert committees.
Please see Table 1.2 at the end of this section for a summary of the level and appraisal of
evidence.
Level I
The level I evidence was four systematic reviews by Hooper, Martin, Abdelhamid, and
Smith (2015), de Waure et al. (2013), Rees et al. (2013), and Cole, Smith, Hart, and Cupples
(2011). These articles were given a level I evidence within the hierarchy based on the type of
study that was conducted. Four systematic reviews performed meta-analysis and one review
consisted of RCTs. The primary and secondary outcomes measured included overall and
cardiac mortality, fatal and nonfatal cardiac events, diet intake, blood pressure, lipid
measurements, amount of physical activity, BMI, and self-efficacy. The Hooper et al. (2015)
systematic reviews consisted of 15 RCTs and 759,000 participants over two years. A significant
clinical finding from this review was the 13% reduction of CHD events with the decrease in
saturated fat intake (RR 0.87, 95% CI 0.74 to 1.03). There was also a clinical significance to
secondary outcomes in LDL-C and systolic and diastolic blood pressure (MD -0.19 mmol/L, 95%
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CI -0.33 to -0.05, MD -0.19 mmHg, 95% CI -1.36 to -0.97, and MD -0.36 mmHg, 95% CI -1.03 to
0.32, respectively) with no clear effects on cardiac mortality.
In the systematic review with meta-analysis by de Waure et al. (2013), 14 high-quality
RCTs consisting of lifestyle interventions in patients with coronary disease were examined. The
trials were evaluated to correlate the impact of lifestyle interventions on the risk for fatal and
nonfatal CV events over at least six months. These interventions consisted of multifactorial
lifestyle components (measures to reduce LDL-C, blood glucose, smoking, stress, and weight
and increase physical activity) and tailored for the individual needs for each patient. This review
consisted of 6,657 participants, and it measured the number of fatal and nonfatal events (MI,
revascularization, and death), overall mortality (all causes), and hospital readmissions. The
authors endorsed the need for secondary prevention programs due to the overall reduction of
fatal cardiovascular events and overall mortality. Secondary outcomes that were significant
included improvements in systolic blood pressure and total cholesterol, LDL-C was not
measured in this review. Fatal CV events were reduced by 18% (RR 0.82, 95% CI 0.69, P =
0.003), and overall mortality was reduced (RR 0.94, 95% CI 0.83 to 1.06, P = 0.32). A decrease
in systolic blood pressure (WMD -4.36 mmHg, 95% CI -6.50 to -2.22) and total cholesterol
(WMD -0.33, 95% CI -0.57 to -0.08) was observed. The indications are significant for the big
picture in patients with CAD, to reduce the number of fatal and nonfatal cardiac events. The
impact of these lifestyle interventions lowers the risk factors and are relevant and reliable to
support lifestyle interventions that are tailored to patient preferences and resources.
Dietary advice for reducing CV risk, addressing the effects among healthy people, was
reviewed by Rees et al. (2013). Rees et al. (2013) reviewed 44 RCTs and used meta-analysis to
determine the significance of the findings of the included studies. The interventions in the RCTs
were either verbal or written advice delivered in person by a healthcare professional among
18,175 participants. The primary outcomes of this study included overall CV risk factors, blood
pressure, lipids, and biomarkers of dietary intake; secondary outcomes included self-reported
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dietary intake. The clinical implications from this systematic review after meta-analysis was the
reduction on systolic and diastolic blood pressure and lipids. Blood pressure was reported in 11
studies. Systolic blood pressure was reduced by 2.61 mmHg (DM -2.61, 95% CI -3.91 to -1.31),
and diastolic blood pressure was lowered by 1.45 mmHg (MD -1.45, 95% CI -2.22 to -0.68).
Lipids were reported in 18 studies with a small, yet significant reduction in total cholesterol of
0.15 mmol/L (MD -0.15 mmol/L, 95% CI -0.23 to -0.06) and in 13 studies LDL-C was reduced by
0.16 mmol/L (MD -0.16 mmol/L, 95% CI -0.24 to -0.08). The DASH diet resulted in the largest
reduction of fat intake, 10.9% (MD -2.39 gm, 95% CI -3.37 to -1.4). Therefore, the pertinent
outcomes of this review support the need to measure baseline and follow-up serum lab values
to measure the consistency of dietary effect and adherence, and support a diet-based
intervention. The DASH diet was used in some of the interventions, which showed the largest
reduction of saturated fat intake which should be considered when deciding on dietary
guidelines for patients to follow.
Cole et al. (2011) proposed to “determine the effectiveness of lifestyle interventions for
the secondary prevention of CHD” in their systematic review which included 21 RCTS and
10,799 participants (p. 2). The duration of the studies was from three months to five years with
follow up every three months. Primary outcomes measured in the review were all-cause
mortality, cardiac mortality, nonfatal cardiac events, and hospital admissions. Secondary
outcomes consisted of diet (total intake of fiber, fruits and vegetables), exercise, blood pressure,
blood lipid levels, health related quality of life, self- efficacy, and medication adherence. From all
of those outcomes, 39 out of 51 participants significantly improved dietary intake of fiber and
reduced intake of sugar, fat, and cholesterol. In 20 studies, physical activity had increased,
especially in overall workload endurance. Blood pressure was reported in five out of thirteen
studies with reported benefits at three and twelve months. Five studies reported significant
improvements in LDL-C. Self-efficacy was reported in one study, at 6 months self-management
improved. These findings relate to the effectiveness of implementing a lifestyle intervention to
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lower the risk of fatal and nonfatal events for patients with CAD. Although self-efficacy was
discussed in one of the RCTs, self-management is an important factor in longevity of a behavior
change and patients must be willing to continue health-promoting behaviors after the project has
ended.
Level II
The level II evidence consisted of one well-organized RCT with substantial implications
for a lifestyle intervention in CAD patients with hyperlipidemia. Applicable findings from the
Stuart et al. (2013) were based on the effects of using a primary care prevention model and
telephone-based support. The outcomes measured in this study included LDL-C, waist
circumference, blood pressure, physical activity, and motivation. This RCT consisted 49
participants who were at risk for developing CV disease, 26 in the intervention group and 23 in
the control group. The intervention included distributing a handbook that provided participants
with dietary meal plans, recipes, and physical activity plans, as well as telephone support from a
trained healthcare professional. The study lasted twelve weeks. Primary outcomes measured in
this study were LDL-C, waist circumference, blood pressure, physical activity, and motivation.
There were no changes in the dose of blood pressure or cholesterol medications for those
patients prescribed medications during the course of this study.
This stability is an important factor to consider for the implementation process and
effects on lifestyle changes. Results were presented as an estimated mean with a set significant
P value of < 0.05. The results of the study showed the intervention group had greater reductions
in LDL-C levels with significant main effect for treatment (F (1, 43) = 15.50, P = 0.0001). Blood
pressures remained stable throughout the study and had no significant outcomes on either
systolic or diastolic pressures, F (1,45) = 15.50, P = 0.60 and F (1, 43) = 0.52 mmHg, P = 0.47,
respectively. Intervention participants experienced weight loss but no significant treatment effect
on waist circumference. There was a positive correlation between weight loss and LDL-C (r =
0.560, n = 26, P = 0.003). These significant outcomes show an effect on dietary and physical
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activity counseling on biomarkers that measure hyperlipidemia and CV risk factors. Also, no
medication changes were made during this study for those participants on blood pressure or
cholesterol lowering medication; this factor is essential to determine whether or not it was the
intervention or a potential change in medication dose or frequency that caused the significant
effects on the measured outcomes.
Level III
Level III studies are well-controlled trials without randomization (Melynk & FineoutOverholt, 2015). In Noe et al. (2014), the patients followed a lifestyle modification and nutrition
intervention. They were combined into three groups: Group A consisted of aerobic and
resistance training sessions four times per week, Group B had two to three times per week, and
Group C participants had no regular physical activity. A total of 75 participants with CV risk
factors were enrolled in this study for six months. Primary outcomes measured were blood
pressure, heart rate, lipid profile, BMI, and exercise tests. BMI significantly decreased, more in
Group A than in Group B (8.7% versus 5.0%). There was also a reduction in systolic and
diastolic blood pressure in Group A and Group B; Group A had a greater reduction in systolic
and diastolic blood pressure than Group B (8.5% and 7.0%; 5.5% and 4.7%). LDL-C had a
decrease of 29.8% in Group A and 21.2% in Group B. Implications for clinical practice support
the incorporation of physical activity into a lifestyle modification intervention and monitoring for
effects on patient’s cholesterol, a major risk factor for a CV event.
In the quasi-experimental study by van den Wijngaart et al. (2015), a nurse-led
multidisciplinary intervention was initiated to improve the CV disease profile in patients with
CVD. Their purpose was to “evaluate the magnitude of change in various modifiable
cardiovascular risk factors, such as body mass index, waist, blood pressure, lipid levels, and
lifestyle parameters, during short- and long-term follow-up” (van den Wijngaart et al., 2015, p.
707). This study consisted of 176 participants over a three to fifteen-month period with follows
every third and sixth months. The intervention retrospectively evaluated profile risk of participant
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and then individualized a treatment plan that involved both medical and lifestyle behavior
changes based on that risk profile. These participants were then observed over the length of the
study. The descriptive characteristics at baseline chart review that researchers included in the
profile consisted of age, gender, blood pressure, BMI, LDL-C, waist circumference, smoking
habits, alcohol usage, and eating habits. The tests used to measure the effect in this study
included a pair t- test or chi-squared and differences between groups were measured by a
univariate ANOVA. At the end of the study, there was a significant reduction in patient’s systolic
blood pressure (138.3  20.7mmHg to 128.7 17.7 mmHg; p <0.01) and LDL-C (2.55  0.87
mmol/L to 2.16  0.73 mmol/L; p < 0.01). Unfortunately, BMI increased from 26.6  4.5 kg/m2 to
27.5  4.8 kg/m2, and patients became less active toward the end of the study. These pertinent
outcomes should be considered when developing a project based on tailoring patient
interventions and the process in which to apply health-behavior change. This study also
contained smoking cessation; there could be a correlation between smoking cessation (-6.7%;
P < 0.0001) and the increase in BMI.
Level IV
The level IV evidence accepted for this literature search was by Al Mheid et al. (2016); a
health-partner administered lifestyle intervention was implemented with 711 university
employees over 2 years- at baseline, 6-months, 1-year, and 2-years. This prospective cohort
study implemented a counseling intervention provided by a trained health professional; the
counseling was based on the AHA’s Life’s Simple 7 healthier lifestyle objectives. The outcomes
measured in this study include vital signs (heart rate, blood pressure, temperature, respirations,
and oxygen saturation), height/weight, and waist to hip ratio, a lipid panel, and metabolic panel.
The results of the study showed a decrease in systolic and diastolic blood pressure at 6 months
(-3.6 mmHg and -2.2 mmHg, p <0.001) and improvements in LDL-C
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(p <0.001). Also, physical activity increased by 6% at 6 months (P = 0.04) and dietary scores
increased by 0.46 for those participants with poor baseline diet scores at 6 months (p <0.001).
These findings support the need for healthcare professionals to be involved and monitor at risk
patients in either the primary or secondary context. This one-on-one counseling intervention,
although not within the outpatient clinical setting and pertains to primary prevention, shows
efficacy of provider-based counseling for decreasing the risk for CV.
Level V
The two level V studies by Salehi-Abargouei et al. (2013) and Tapsell and Neale (2016)
were systematic reviews that analyzed descriptive studies. Salehi-Abargouei et al. (2013)
analyzed the effects of the DASH diet on CV disease by summarizing information and
assessing “the magnitude of the relation between imitating a DASH-style diet and CVDs or its
major subclass, like CHD, stroke, and HF in prospective cohorts” (p. 2891). This systematic
review consisted of six cohort studies with 260,000 adults with or at risk for CV disease, and the
intervention reviewed was imitating a DASH-style diet. The outcomes measured were either
incidence of CV disease, CAD, or stroke. Three out of the six studies included data in relation to
CHD; in 144,337 adults eating DASH diets lowered the risk for CAD (RR 0.79, 95% CI, 0.710.88, P < 0.001). The DASH diet has shown efficacy in lowering the risk for CV disease and
potential fatal outcomes.
Tapsell and Neale (2016) evaluated the effect of interdisciplinary interventions on risk
factors for lifestyle disease and its risk factors. These risk factors are weight, lipid levels,
glycemic control, and blood pressure. This systematic review and meta-synthesis of sixteen
studies (7 RCTs, 3 pseudorandomized, and 6 pre- and post- test results without comparisons to
a control group) and 15,890 adults with chronic disease. The outcomes measured in this review
were weight, lipid levels, hemoglobin A1c, and blood pressure. The review also synthesized
characteristic features of successful interventions for lowering risk factors for chronic disease.
As a result, one out of six studies found greater improvements in blood lipids, and in five studies
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there were reductions in blood pressures. In addition, exercise and/or behavior modifications to
dietary advice resulted in significant reductions in body weight. The synthesized features
showed there were greater effects when there was greater amount of contact between health
professionals and participants.
Level VI
The level VI evidence for this EBP project was a cross sectional study, known as the
EUROASPIRE IV study, by Kotseva et al. (2016). The EUROASPIRE IV study was conducted
by the European Society of Cardiology to identify patient risk factors, describe management
through lifestyle and drug therapies, and provide an objective assessment of clinical
implementation of current scientific medical knowledge (Kotseva et al., 2016). It consisted of
collecting data from medical records (16,426 records) and post hospitalization interviews (7,998
interviews) at six months. The population of this study included patients less than 80 years old
with CAD who had a CABG, PCI, or ACS. Lifestyle factors and targeted anthropometric
measures, i.e. physical activity, waist circumference, blood pressure, LCL-C, smoking habits,
cardioprotective medications, diabetes, and cardiac rehab attendance. The findings revealed
physical activity increased by followed advice from a health or exercise professional (23.5%),
participated in gym attendance or an exercise program (52.8%), and increased overall daily
physical activity (17.4%). Patients’ knowledge of weight (93.4%) and blood pressure (86.7%) at
baseline was sufficient, but most patients were unaware of their current cholesterol level
(48.9%) or waist circumference (29.3%).
Level VII
The level VII evidence consisted of one expert opinion by Drakopoulou et al. (2016), two
expert panels by Eckel et al. (2014) and Stone et al. (2014), and one literature review by Rippe
and Angelopoulos (2014). The expert opinion by Drakopoulou et al. (2016) summarized the
current recommendations for the lipid profile management of patients with CAD to present
behavior modifications and medical treatment, applying the guidelines established by the
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ACC/AHA and European Society of Cardiology. These implications are for the lifestyle and
treatment of patients with CAD. The major focuses of this expert opinion included lipid levels,
blood pressure, behavioral and psychosocial risk factors, smoking cessation, and body weight
control. Overall improvements suggested increasing vegetable, fiber, whole grains, low-fat dairy,
poultry, legumes, fish, and nuts for dietary modification. Incorporating daily physical activity was
also advised to reduce LDL-C levels by 3-6 mg/dL when performed for 24 weeks in duration
(greater than three days per week for forty minutes each session). A second lipid panel should
be collected at 4-12 weeks after initiating statin therapy or if there is a change in lifestyle to
further determine patient’s adherence (then performed every 3-12 months). These implications
for practice support the impact of a lifestyle modification intervention on patients with CAD. By
implementing dietary and physical activity changes, the risk for a major CV event can be
significantly reduced by monitoring lipid panels and blood pressures.
In the expert panel by Eckel et al. (2014) from the ACC/AHA consisted of sixteen
members in the Expert Work Group to develop a guideline based on high-level RCTs,
observational studies, systematic reviews with meta-analysis. The purpose of this guideline is to
“prevent CVDs, improve management of people who have these disease through professional
education and research; and develop guidelines and standards and policies that promote
optimal patient care and CV health” (Eckel et al., 2014, p. 2961). These guidelines aim to reflect
outcomes of total cholesterol, LDL-C, blood pressure, levels of physical activity, and dietary
habits and emphasized the focus on low-fat dietary patterns, which includes a decrease in fats
(macronutrient) by following a DASH or Mediterranean diet. The guidelines also list ten lifestyle
recommendations that support the need for tailored interventions as there is an inverse
relationship between levels of physical activity and rates of CVD and beneficial effects on lipids,
cholesterol, and blood pressure.
Another ACC/AHA guideline widely used in the clinical setting is by Stone et al. (2014)
expert panel. This panel consisted of sixteen members that reviewed systematic evidence of
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RCTs and systematic reviews with meta-analysis of RCTs. This guideline is intended to guide
the treat adults, 21 and older, to complement the NHLBI CV health risk reduction guidelines.
Thus, the major aim of this guideline on the treatment of blood cholesterol to reduce CV risk in
adults is to monitor and treat blood cholesterol. Once again, Stone et al. (2014) emphasized that
lifestyle is the foundation for ASCVD risk factors and should be continuously discussed with
patients, but moreover, the recommended guideline focuses on four major statin benefit groups
and does not recommend any specific LDL-C target goal. In secondary prevention, a high
intensity statin medication provides the most benefit for patients less than or equal to 75 years
of age. The care for the patient with CAD and hyperlipidemia should be individualized and
clinical judgment should be based on experience and health status for target LDL-C goals.
The last piece of evidence is a literature review over the guidelines by Rippe and
Angelopoulos (2014). Rippe and Angelopoulos (2014) summarized a recent review on how
specific lifestyle strategies could be implemented to lower risk of CV disease based on the AHA
Strategic Plan for 2020. This review discussed BMI and weight, amount of physical activity per
week, blood pressure, dietary patterns, and smoking habits. Overall, patient counseling
contributed a modest or sustained weight loss and should be utilized to achieve meaningful
health benefits. In regards to dietary patterns, DASH dietary adherence improves overall CV
health and should be recommended in the clinical setting. Patients should participate in
moderate to intense aerobic and resistance training physical activity at 3-4 sessions (40 minutes
per session). This review also reiterated a discontinuance of targeted treatment for goals for
LDL-C therapy and instead reinforces the four major statin benefit groups, which is found in the
original 2014 ACC/AHA guidelines by Stone et al. (2014). Rippe and Angelopoulos (2014) also
reiterate the Eighth Joint National Committee (JNC 8) recommendations for lifestyle blood
pressure regulation. These recommendations include regular aerobic exercise, limiting salt
intake, maintain a healthy body weight, and smoking cessation. This article incorporates the
ACC/AHA and JNC 8 guideline support to continue reinforcing lifestyle modifications for CAD
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patients ready to make a behavioral change and provides rationale for implementing a lifestyle
intervention focusing on improving CAD health.
Construction of Evidence-based Practice
The construction of EBP was based on the synthesis of the appraised literature, then
developed into a best practice model.
Synthesis of Critically Appraised Literature
The literary evidence was synthesized to address the targeted population, emerging
implications for practice, measurable outcomes, and duration of interventions. The age of the
population in the literature focused on adults over age 18 (Cole et al., 2011; Hooper et al., 2015;
Kotseva et al., 2016; Rees et al., 2013; van den Wijngaart et al., 2015). Others focused on
adults ages 21 and over, age 28 or older, or age 30 and over (Noe et al., 2014; Stone et al.,
2014; Stuart et al., 2013).
Al Mheid et al. (2016), Noe et al. (2014), Rees et al. (2013), Stuart et al. (2013), and Tapsell &
Neale (2016) included healthy adult cohorts that were at risk for developing CAD (primary
prevention). Cole et al. (2011), de Waure et al. (2013), Hooper et al. (2015), Kotseva et al.
(2016), Salehi-Abargouei et al. (2013), and van den Wijbgaart et al. (2015) included adults with
an established CAD diagnosis (secondary prevention). Primary prevention is applied to the
intended population due to the effectiveness of interventions on healthy adults.
Implications for best practice are lifestyle modification programs for a health behavior
change. Counseling is a necessary facilitator to include advice giving and providing patients with
evidence-based resources, such as handouts, sample menus, and heart healthy recipes (Al
Mheid et al., 2016; Cole et al., 2011; de Waure et al., 2013; Eckel et al., 2014; Hooper et al.,
2015; Kotseva et al., 2016; Rees et al., 2013; Ripper & Angelopoulos, 2014; Stone et al., 2014;
Stuart et al., 2013, Tapsell & Neale, 2015). As a part of this intervention, it is strongly
recommended that the counseling intervention and resource handout be individualized to
patient preferences with a multifactorial and interdisciplinary approach incorporating dietary
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changes and physical activity. Physical activity recommendation consists of three to four
sessions per week at forty minutes per session, according to the 2014 ACC/AHA national
guidelines (Al Mheid et al., 2016; Drakopoulou et al., 2016; Eckel et al., 2014; Noe et al., 2014;
Rippe & Angelopoulos, 2014). A DASH-style or modified fat diet must be followed to lower CV
risk factors with support from the AHA (Drakopoulou et al., 2016; Eckel et al., 2014; Hooper et
al., 2015; Rees et al., 2013; Rippe & Angelopoulos, 2014; Salehi- Abargouei et al., 2013; van
den Wijngaart et al., 2015). Self-efficacy and self-management skills were evaluated to observe
the impact on long-term behavior changes (Cole et al., 2011; de Waure et al., 2013). To make
these lifestyle modifications a success, close engagement with healthcare providers is essential,
especially if providers follow the 2014 ACC/AHA guidelines; counseling can be achieved
through face-to-face, handouts, and/or telephone support (Al Mheid et al., 2016; Cole et al.,
2011; de Waure et al., 2013; Drakopoulou et al., 2016; Eckel et al., 2014; Noe et al., 2014;
Rippe & Angelopoulos, 2014; Stone et al., 2014; Stuart et al., 2013; Tapsell & Neale, 2015; van
den Wijngaart et al., 2015).
Anthropometric outcomes were used to objectively measure adherence and effects of
CV biomarkers. These outcomes consist of measuring weight and height to calculate BMI. The
literature measured primary and secondary outcomes at baseline and throughout the duration of
the studies. Lipid panel and blood pressure were ordered to evaluate total cholesterol, LDL-C,
and/or HDL-C (Al Mheid et al., 2016; Cole et al., 2011; Drakopoulous et al., 2016; Eckel et al.,
2014; Hooper et al., 2015; Kotseva et al., 2016; Noe et al., 2014; Rees et al., 2013; Stone et al.,
2014; Stuart et al., 2013; Tapsell & Neale, 2016; van den Wijngaart et al., 2015). Other
measurements that affect CV risk included in the studies were waist circumference, BMI, dietary
habits, and physical activity (Al Mheid et al., 2016; Cole et al., 2011; Eckel et al., 2014; Hooper
et al., 2015; Kotseva et al., 2016; Noe et al., 2014; Rees et al., 2013; Rippe & Angelopoulos,
2014; Salehi-Abargousei et al., 2013; Stuart et al., 2013; Tapsell & Neale, 2016; van den
Wijngaart et al., 2015). CV events or incidence were also included as primary or secondary
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outcomes in which fatal or nonfatal events were considered significant findings (Cole et al.,
2011; de Waure et al., 2013; Hooper et al., 2015; Salehi-Abargouei et al., 2013). As a result of a
lifestyle counseling and modification program, anthropometric biomarkers, BMI, dietary habits,
physical activity, and CV events showed clinically significant improvements.
Best Practice Model Recommendation
The best practice model recommendation for this EBP project targets adults ages 18
and older with coronary artery disease and hyperlipidemia to focus on secondary prevention in
the clinical setting for optimal risk reduction for a secondary fatal or nonfatal coronary event. A
lifestyle modification program, that consists of a brief, yet effective counseling session focusing
on multifactorial lifestyle changes for health promotion with a complementary resource tool, was
implemented to lower secondary CV event over six months. The intervention was administered
by the project manager who will continually monitor patient progress. Face-to-face and
telephone modalities was used to deliver the intervention and follow up patients during this
project. The participant handout was consisted of expanding on the knowledge and awareness
of health; then, a discussion regarding personal risk factors will occur to promote patientcentered care, and a handout will be distributed to promote a heart healthy lifestyle that is
supported by the AHA. An introduction regarding the meaning of lipid panel values and effect on
health was initiated and what certain foods, low in saturated fat, and exercise can do to promote
CV health. Dietary, physical activity guidelines and DASH-style diet will be included, as
mentioned in the supportive literature. Participants were also required to complete the RateYour-Plate for Blood Cholesterol tool (Gans, Hixson, Eaton, & Lasater, 2000) and the Rapid
Assessment of Physical Activity (RAPA) (University of Washington, 2006) evaluate their dietary
and physical activity habits. Primary and secondary outcomes were measured at baseline and
six months; the primary outcome being measured was a baseline and follow up lipid panel for
LDL-C, and the secondary outcomes being measured are blood pressure, BMI, dietary habits,
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and physical activity. Findings were then analyzed from the participant’s lab values and changes
from dietary and physical activity recommendations.
How the Best Practice Model Will Answer the Clinical Question
This best practice model answered the clinical question by addressing the clinical
problem of a cost-effective, time-efficient, patient-centered intervention to reduce hyperlipidemia
in CAD adult patients. It is recommended in the guidelines that lifestyle changes should be a
major focus to changing the status of cardiac risk, however, not all providers have extensive
time to do this. If a patient-centered handout was developed to assist the patient toward making
these changes, there might be clinical benefit of using it in long-term clinical practice. Therefore,
this lifestyle modification program will include a brief counseling session and patient-centered
handout. The counseling session will include the meaning and impact of cholesterol on cardiac
health and then, dietary and physical activity recommendations will be reviewed in the table of
contents of the handout.

CHAPTER 3
IMPLEMENTATION OF PRACTICE CHANGE
The implemented practice change occurred over six months and was a facilitated health
behavior change. By promoting cardiovascular health for adult patients with coronary artery
disease, a patient-guided resource, paired with face to face counseling, provided participants
with basic yet vital information for improving health practices. The resource also included a
patient-specific component at the end of each section to allow participants to reflect on their
self-efficacy and status of behavior change. The overall goals of this EBP implementation is to
lower secondary risk for nonfatal and fatal cardiac events for adult patients with coronary artery
disease.

LIFESTYLE MODIFICATION PROGRAM

37

Participants and Setting
The participants for this EBP project were adult patients with an established coronary
artery disease diagnosis. The implementation of this EBP project took place at a local
cardiology outpatient practice affiliated with a not-for-profit with a diverse patient population. A
manual review of the patients’ electronic health records, determined which patients met the
inclusion criteria. Inclusion criteria included the following qualifications: adults ages eighteen
and older, previously established CAD diagnosis, hyperlipidemia diagnosis, ability to perform
physical activity, and access to a phone and internet resources. Participants were excluded
from this study if they are children, under the age of eighteen, pregnant or breastfeeding, living
with cognitive impairment or delays, unable to exercise, following strict diets, living with an
eating disorder, and/or receiving dialysis treatment. Once patients met the inclusion criteria,
either the nurse practitioner or the cardiologist verbally discussed the purpose of the project and
eligibility with the patient for recruitment. If the patient was agreeable, then he or she met with
the project manager to further discuss the project, sign the informed consent, and receive the
lifestyle counseling portion of the intervention. Participants were recruited in September 2018,
pre-intervention measurements taken at baseline and at six months.
Outcomes
The primary outcome of the project was the LDL-C (mg/dL) drawn from a fasting lipid
panel. Secondary outcomes that were measured include blood pressure (mmHg), BMI (kg/m2),
dietary habits, and physical activity assessment. Dietary habits were assessed by instructing the
participant in how to fill out the patient-focused pre- and post- intervention tool. The RYP for
Blood Cholesterol scores was based on dietary choices ranging from 23 to 69. Scores were
tallied by patient’s selection of dietary choices. Ranges 23-38 indicate there were many ways to
make healthier dietary choices, a score within the range of 39-54 mean there were a few ways
to make healthier dietary choices, and a score of 55-69 verified healthy dietary choices are
being made.

LIFESTYLE MODIFICATION PROGRAM

38

The RAPA tool is a quick assessment in which providers can quickly assess physical activity
and has two categories, aerobic activity and strength and flexibility. A score of 1 refers a
sedentary lifestyle, score of 2 is an under-active patient, score of 3 is being under-active to
lightly active, scores 4 and 5 regularly exercises but is underactive, and scores of 6 and 7 are
active. Fore strength and flexibility, participants who perform activities to increase muscle
strength receive a score of 1, and if a participant does regular stretching and/or yoga activities,
they receive a score of 2. A score of 3 is given if a participant both performs strength and
stretching activities. Outcome data was compared to each other at baseline and 6 months post
intervention. These outcomes were helpful to determine the indications to continue this practice.
Intervention
The intervention for this EBP project was a multifactorial strategy to promote lifestyle
management in coronary artery disease patients with CAD. The intervention included measuring
participant’s LDL-C, blood pressure, BMI, RYP for Blood Cholesterol Tool score (Appendix B),
and RAPA (Appendix C) score significance at baseline and 6 months. Clinical significance was
important to determine if this practice helped lower LDL-C levels and encouraged patients to
maintain a heart healthy lifestyle. The intervention also included an individualized counseling
session, following the guidelines set forth by the ACC/AHA. In this counseling session, the
project manager and participant reviewed the benefits and risk of participation, expected followup, follow-up appointment, and review of baseline LDL-C, blood pressure, and BMI. Participants
also completed the Rate-Your-Plate Tool for Blood Cholesterol (Gans et al., 2000) questionnaire
for dietary habit assessment and the RAPA (Topolski et al., 2006) for physical activity pattern.
The participants then received a self-guided patient booklet that contains a health profile
record, dietary and physical activity guidance, and stress management relief techniques, used
with permission from the AHA and NIH. Participants were instructed to complete each section
every week and complete the self-guided patient component. The self-guided component was
intended to increase patient knowledge and self-efficacy to build lifelong learning and disease
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management skills. A telephone call follow-up was initiated the first week post intervention, and
monthly, thereafter. The telephone follow-up was intended to assess participant perspective on
the current status of the intervention and remind patient to stay on track with the sections of the
booklet. Participants were expected to obtain their follow-up LDL-C sample prior to their 6month follow-up office appointments. The 6-month follow-up appointments involved meeting
with the healthcare provider to review lab work and then meeting with the project manager to
review completed portions of the patient booklet, answer any questions, and complete the RateYour-Plate Tool for Blood Cholesterol (Gans et al., 2000) for dietary assessment and the RAPA
tool for the level of physical activity completed (Topolski et al., 2006). Data was updated as
received by participants and analyzed after the 6-month follow-up.
Planning
This EBP project was a result of a clinical problem discovered during clinical rotations.
The clinical problem was the observation of patient disconnect from their LDL-C levels and
knowledge of a heart healthy lifestyle. A literature search was performed to determine a best
practice strategy to improve the health of patients with CAD and hyperlipidemia. The Health
Promotion model was used to guide best practice for a lifestyle modification intervention. Project
site was selected based on the patient population and need for advanced practice nursing
intervention. Permission was obtained from facilitators at the project site to conduct the project
and collect data. Site facilitators were kept updated during this process.
Once IRB approval was received, patients were recruited based on the inclusion and
exclusion criteria. The electronic medical records of patients with upcoming appoints during the
recruitment period were reviewed. Site facilitators were notified ahead of time who qualified for
the project, so they could verbally convey project details to the convenience sample of potential
participants. Once the patient agrees to participate in the EBP project was initiated based on
strategies listed as the intervention. The implementation involved all aspects of the clinical site
including the health care providers and the office medical assistant, who obtained vital
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measurements. Intervention was directly implemented by the project manager who will also
perform follow-up telephone calls and the 6-month follow-up assessments.
Data
Measures
The data measured in this EBP project will be a LDL-C, blood pressure, BMI, dietary,
and physical activity patterns. A 12- hour lipid panel was drawn. To ensure blood pressure,
weight, and height is valid, project manager ensured medical assistant took patient
measurements with the appropriate technique each time. Blood pressure were measured with
the patient in the sitting position, legs uncrossed, feet planted on the floor, arm upward in
pronation resting at chest level on a solid surface, and with the same blood pressure machine
each time (standard technique). Height was measured with the device, and weight was taken on
the same scale, zeroed for weight accuracy. The tools used to collect these measurements
were the same during each collection for each participant.
Dietary and physical activity assessment tools were used to evaluate dietary patterns
and physical activity levels. The dietary assessment tool utilized in this EBP project was the
Rate-Your-Plate Tool for Blood Cholesterol (Gans et al., 2000). This tool was studied and
shown to be both valid and reliable. Physical activity assessment was evaluated using the
RAPA tool (Topolski et al., 2006). This tool is easily accessible for healthcare providers and
patients and is a valid form of measuring physical activity in the clinical setting.
Collection
To collect data, participant privacy was a priority objective. Data was coded by using a
random assignment of numbers. Data was collected by venous sampling for fasting lipid profile
to read LDL-C levels. Anthropometric data was collected by office personnel and data typed into
electronic record for project manager viewing and use. The Rate-Your-Plate Tool for Blood
Cholesterol (Gans et al., 2000) and RAPA survey were collected by project manager in paper
and pencil format that will contain the patient’s randomly assigned number on the upper right-
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hand corner to correlate with patient identification that was followed throughout the duration of
the project. During the duration of the project, data was recorded in a flowsheet and kept secure
in a password protected computer. The data was inserted into a statistics software program
(SPSS) for statistical analysis.
Management and Analysis
The management of patient data was in the form of paper and online data recording.
Data collected from participants were kept on site unless needed for input analysis; data was
inserted into the latest version of SPSS software to determine the significance of the
intervention.
Participant data was protected in a lockbox in which the project manager was the only one who
has the code and key. Information was stored at project site in a locked filing system behind
locked doors after hours unless needed for input into SPSS version 25 software or further
analysis. The participant data was analyzed by collecting final results of participant LDL-C,
blood pressure, and BMI. Pre- and post- intervention results will be compared using paired ttests to determine clinical significance. Dietary scores results will be compared pre- and postintervention using paired t-tests, as well. Physical activity assessment will be assessed using
the scores from the RAPA tool (Topolski et al., 2006). Data will be analyzed by comparing preand post- intervention scores using paired t-test.
Descriptive statistics were used for demographic data collected during this EBP project.
Chi-Square test will be used to analyze differences between groups. Demographics collected
were gender, marital status, identifiable race/ethnicity, income, highest level of education
medication use, and years diagnosed with CAD This data was used to display differences
among demographic groups.
Protection of Human Subjects
To protect participants from unethical behavior and unnecessary harm, IRB approval
was obtained from both the educational and professional institutions where the project took
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place. Prior to IRB approval, project manager was able to gain clinical site permission and a
documentation of approval for EBP project. This project contained a level of risk that is minimal
and provided full disclosure of project intent to IRB and future participants, falling under an
expedited review from both IRBs.

CHAPTER 4
FINDINGS
This evidence-based practice project focused on the reduction of lipid levels in adult
patients with CAD. These patients were counseled regarding lifestyle changes according to the
ACC/AHA guidelines. A lifestyle modification intervention was designed based on best practice
found in an extensive literature search. After completion of the implementation phase, the
findings were analyzed. The following analysis describes the demographics and outcomes of
the intervention.
Participants
The participants were recruited from September 2018 and were followed up in January
and February 2019 at a local northwest Indiana cardiology practice. A total of 14 patients
participated for the full six months. There was no attrition throughout the duration of the project.
The purpose of this project was to determine the impact of a patient-led lifestyle modification
intervention for adult patients with CAD.
The 14 participants were followed over a 6-month time period, after the initial counseling
session, with monthly phone call follow-ups to monitor for adherence to the lifestyle modification
intervention. Primary and secondary outcomes were measured pre-intervention and six months
post-intervention. There was no attrition; all fourteen participants completed the study as
instructed, possibly due to the close follow-ups and ease of contacting the project manager.
Characteristics
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The participant demographic characteristics were gender, marital status, race/ethnicity,
annual household income, highest level of education completed, taking a medication to lower
cholesterol/lipids, years diagnosed with CAD, and range of ages. Based on the demographic
data form completed by the participant, the information was placed into SPSS version 25 for
frequency and mean analysis. Of the recruited participants (N = 14), 85.7% (n = 12) were male,
and 78.6% (n = 11) were married (see Figure 4.1). The rest of the participants (n = 3) were
either single (n = 1) or widowed (n = 2); no one selected divorced. In regards to race ethnicity,
92.9% (n = 13) of participants identified as white or Caucasian, and the remaining participant
(n = 1) identified as black or African American. Household income was placed into range groups
that varied from less than $50,000, $51,000 - $75,999, $76,000 - $100,999, $101,000 $150,999, greater than $151,00, or preferred not to answer. Figure 4.2 depicts the ranges of
household income. A cumulative 57.1% (n = 8) made either less than $50,999 (n = 4) or
$51,000 - $75,999 (n = 4).
The highest level of education completed was high school diploma or equivalent, which
consisted of 42.9% (n = 6) of participants. 21.4% (n = 3) had a technical or vocational degree,
14.3% (n = 2) had associate’s degrees, and 21.4% (n = 3) has a master’s degree. TAll (n = 14)
participants were prescribed statin-lowering pharmacological therapy. The length of CAD
diagnosis was listed in year range groups; 71.4 % (n = 10) of the participants have been
diagnosed for greater than 10 years. The other participants (n = 4) have been living with CAD
for 5 – 10 years (n = 3) or less than 6 months (n = 1). The participants then selected their age
range on the demographic questionnaire. Age ranges included 18 – 29 years, 30 – 40 years,
41- 50 years, 51- 60 years, 61 – 70 years, 71-80 years, 81- 90 years, and 91 years and older.
Figure 4.3 displays the frequency of the age distribution; the majority, 42.9% (n = 6), of
participants were between ages 61 – 70 years. Table 4.1 and 4.2 demonstrate the overall
participant demographic characteristics and pre-intervention means for primary and secondary
outcomes.
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Figure 4.1

MARITAL STATUS
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Figure 4.2

HOUSEHOLD INCOME
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Figure 4.3

AGE RANGE
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Table 4.1
Participant Characteristics
Characteristic

Frequency
n (%)

Gender
Male
Female

12 (85.7)
2 (14.3)

Marital Status
Single

1 (7.1)

Married

11 (78.6)

Widowed

2 (14.3)

Race/Ethnicity
White

13 (92.9)

Black

1 (7.1)

Annual household income
< $50,999

4 (28.6)

$51,000 - 75,999

4 (28.6)

$76,000 – 100,999

1 (7.1)

$101,000- 150,999

2 (14.3)

$151,000 >

1 (7.1)

Prefer not to answer

2 (14.3)

Highest level of education completed
High school diploma

6 (42.9)

Technical/Vocational

3 (21.4)

Associate’s degree

2 (14.3)

(continued)
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Table 4.1
Participant Characteristics (continued)
Characteristic

Frequency
n (%)

Highest level of education completed
High school diploma

6 (42.9)

Technical/Vocational

3 (21.4)

Associate’s degree

2 (14.3)

Master’s degree

3 (21.4)

Years with CAD
< 6 months

1 (7.1)

5-10 years

3 (21.4)

> 10 years

10 (71.4)

48
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Table 4.2
Primary and Secondary Outcomes
Outcome

Pre-Intervention
M (SD)

Post-Intervention
M (SD)

LDL-C

67 (20.78)

62 (16.11)

BMI

33.33 (5.74)

29.74 (4.06)

Systolic

133 (15.21)

132 (22.21)

Diastolic

78 (9.50)

76 (8.75)

RAPA 1

4 (1.83)

5 (0.94)

RAPA 2

0.5 (1.09)

2 (0.92)

BP

RYP for
48 (6.8)
Blood Cholesterol

58 (4.58)
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Changes in Outcomes
The primary outcome analyzed was the pre- and post- intervention LDL-C levels.
Secondary outcomes examined were: BMI, BP, RYP for Blood Cholesterol scores, and RAPA
scores. The data were analyzed to identify any relationship between the demographic
characteristics on primary and secondary outcomes using a Chi Square with a statistical
significance level of p <.05
Statistical Testing
The statistical method used for identifying possible correlations on LDL-C levels, BP,
BMI, dietary choices, and physical activity was the paired samples. For the pre- and postintervention data, a paired- samples t - test was performed to analyze for clinical significance.
Demographic characteristics were measured on either a nominal or ordinal level, based on the
type of data collected. LDL-C was measured based on interval-level data, as well as the mean
score for secondary outcomes, BMI, BP, RYP for Blood Cholesterol score, and RAPA score.
Table 4.2 displays data for pre- and post-intervention outcomes. Figure 4.4 compare preintervention and post-intervention LDL-C levels, and Figure 4.5 and 4.6, respectively, compare
pre-intervention and post-intervention RYP for Blood Cholesterol and RAPA scores.
Primary outcome
The primary outcome of this EBP project was a comparison of participant’s LDL-C preand post- intervention. and A side by-side histogram (Figure 4.4) demonstrates the
comparison between pre- and post- intervention information. The mean pre-intervention data
was 67 mg/dL (SD = 20.78), and the post-intervention mean was 62 mg (SD = 16.11). The
significance of the intervention was determined by running a paired t-test. The paired t- test
revealed t (13)= .759, p<.05 95% CI [-8.97, 18.68] and significance level of
.461, which is not clinically significant (see Table 4.3).
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Figure 4.4

PRE- AND POST-INTERVENTION LDL-C LEVELS
Pre-intervention LDL-C

Secondary outcomes

Post-intervention LDL-C
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The secondary outcomes measured in this EBP project were BP, BMI, dietary habits,
and amount of physical activity. The means for these secondary outcomes are listed above in
Table 4.3. Results for significance were based on the collected post-intervention significance of
the paired t-tests. SBP (t(13)= .056, p<.05 95% CI [-13.33, 14.05]) and DBP (t(13)= .886, p<.05
95% CI [-3.39, 8.11]) with clinical significance levels of .956 and .392, respectively, which is not
considered to be clinically significant. For BMI, the results of the paired t-test were t(13)= 1.655,
p<.05 95% CI [-1.00, 8.30] and significance level of .122 and is not clinically significant.
Dietary habits were measured by having participants fill out the RYP for Blood
Cholesterol questionnaire. These scores were based on eating habits consistent with the
ACC/AHA recommendations for heart healthy living. The pre-intervention mean score was 48
(SD = 6.8), and the post-intervention score was 58 (SD = 4.58), also displayed in Figure 4.5.
After running a paired samples t-test, the results concluded t(13)= -4.237, p<.05 95% CI [-15.10,
-4.90] with a significance level of .001, which is considered clinically significant. For physical
activity, participants were asked to complete the RAPA questionnaire, which has two sections.
The first part of the RAPA questionnaire contained amount and type of physical activity, and the
second part contained questions regarding strength training and flexibility. The mean preintervention score for the first part was 4 (SD = 1.83) and a post-intervention mean was 5 (SD =
0.94). A paired samples t-test was conducted which resulted a t(13)= 2.421, p<.05 95% CI [2.57, -.15] and a significance level of .031, which is significant. The second part of the RAPA
tool pre-intervention mean was 0.5 (SD = 1.09) and a post-intervention mean of 2 (SD = 0.92).
A paired t-test was showed significance, t(13)= -4.583, p<.05 95% CI [-2.21, -.79] with a
significance level of .001. Participant results were significant for dietary and physical activity
habits.
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Figure 4.5

DISTRIBUTION OF RYP FOR BLOOD CHOLESTEROL TOOL SCORES
Pre-Intervention RYP scores

Post-Intervention RYP scores
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Figure 4.6

DISTRIBUTION OF RAPA 1 AND 2 SCORES
Pre-Intervention RAPA 1 Scores

Post-Intervention RAPA 2 Scores

Pre-Intervention RAPA 2 Scores

Post-Intervention RAPA 2 Scores
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Significance
Table 4.3 contains the complete display of the significance of primary and secondary
outcomes.
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Table 4.3
Paired-Samples t-test Comparison for Primary and Secondary Outcomes

Outcome

M (SD)

LDL

N

df

14

13

Sig. (2-tailed)

Std. Error Mean

.461

Pre

66.57(20.78)

5.55

Post

61.71(16.11)

4.31

SBP

14

13

.956

Pre

132(15.21)

4.07

Post

132(22.21)

5.94

DBP

14

13

.392

Pre

77(9.50)

2.54

Post

75(8.75)

2.33

BMI

14

13

.122

Pre

33.33(5.74)

1.53

Post

29.74(4.06)

1.08

RYP

14

13

.001

Pre

48(6.80)

1.82

Post

58(4.58)

1.22

RAPA1

14

13

.031

Pre

4(1.83)

.49

Post

5(.94)

.25

RAPA2

14

13

.001

Pre

.5(1.09)

.29

Post

2 (.92)

.25
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CHAPTER 5
DISCUSSION
The purpose of this EBP project focused on the effectiveness of a lifestyle modification
intervention that aids in pharmacological therapy (if applicable) to improve cholesterol levels in
adults with coronary heart disease. The primary outcome of lowering LDL-C levels by a targeted
lifestyle modification counseling session has been shown to lower cardiovascular risk, thus
reducing patient’s risk for a major cardiac event. Secondary outcomes included measuring
effects on blood pressure, body mass index (BMI), and dietary and physical activity changes.
The results from the data were interpreted to explain and address the PICOT question and
purpose of this EBP and relate findings to future implications in advanced nursing practice,
theory, research, and education.
Explanation of Findings
Primary and Secondary Outcomes
The overall impact of the lifestyle intervention and counseling on LDL-C levels was
insignificant (p= .461), as there was no significant difference in LDL-C pre- and postintervention. This insignificant clinical finding may have been due to the fact that participants
had a therapeutic LDL-C level prior to implementation and were prescribed a cholesterollowering medication before the course of the implementation period. However, therapeutic LDLC levels were maintained throughout the duration and no cardiac events or deaths occurred.
The majority of participants were between the ages of 61-70 (42.9%), all taking cholesterol
lowering medications (100%), and were diagnosed with CAD and hyperlipidemia for ten years or
more (71.4%). Inferences can be made that there is longevity with CAD and increased
education exposure in correlation with medications, and interactions with health providers.
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The secondary outcomes measured were SBP, DBP, BMI, dietary habits, and physical
activity. SBP and DBP were not clinically significant in pre- and post- intervention blood
pressure readings. (p= .956, p= .392), which remained consistent and unchanged. Although
there appeared to be a decrease in overall BMI means pre- and post- intervention, there was no
significance for clinical implications in the reduction of BMI.RYP for Blood Cholesterol tool
results showed significance. There was an improvement in dietary choice scores after six
months (M= 58, 4.58), suggesting lifestyle modification intervention impacted participants
dietary choices. The RAPA tool, that assessed for physical activity levels, had a significant
increase in the type and amount of both physical activity and strength and flexibility. The data
did answer the PICOT question of lowering blood cholesterol in six months; it maintained levels,
but pre-intervention levels were therapeutic. There was a reduction in risk factors associated
with secondary cardiac events, as supported by the significance found in measuring secondary
outcomes.
In the review of literature, the DASH diet or “heart healthy” diet lifestyles reported in
Rees et al. (2013) which included a reduction of fat intake and healthy eating habits were
consistent with the findings from this EBP project. Cole et al. (2011) systematic review, reported
that an increase in physical activity would be observed post-lifestyle modification intervention.
Self-efficacy and management of disease was mentioned in several studies and was one of the
primary foci when developing this intervention. Participants cholesterol, blood pressure, and
BMI remained stable, which reduces risk factors for secondary fatal cardiac events. Provider
involvement with valid dietary and physical activity measurement tools improved participant selfmanagement outside the clinical setting. There were no major deviations of LDL-C levels in this
project. There were updates for blood cholesterol management guidelines in 2018. Overall, the
results from this EBP project was consistent with the current literature search using key search
terms.
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Evaluation of Applicability of Theoretical and EBP Frameworks
Theoretical Framework
Pender’s Health Promotion model consists of four major interacting concepts which
influence patient’s health promotion. Individual counseling sessions were implemented as part
of the intervention to focus on patient dietary and physical activity preferences. Participants
consented based on their desire to reach optimal cardiac health with the hope of improving
current lifestyle choices for their future health. The APN role as leader, consultant, clinician, and
educator ere emphasized to improve access to care for patients, meeting healthcare and
personal goals. Leader role was fulfilled through leading the EBP project, and researching and
planning the intervention, and conducting counseling sessions and follow-up. Health was
optimized by utilizing the best appraised literature to connect relationship between patient and
APN. A behavioral intervention was created based on interacting participant’s current state of
health with self-efficacy perception. Compliance and effectiveness was determined by
maintenance or improvement in LDL-C measurements.
Environment impacts participant healthcare decisions based on culture, socioeconomics,
preferences, and access. The context affects the overall schema of participants view of health
and feelings regarding a self-led. During each counseling session, the concept of environment
was discussed to promote interest and personal impact of a heart healthy lifestyle and access to
preferences for resources, such as grocery store locations, restaurant menus, physical
activities, recipes, online support, and smartphone applications. The APN role promotes overall
national healthcare goals consistent with guidelines recommendations by implementing this type
of intervention.
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This health promotion theory was appropriate for this EBP project based on the
incorporation of the nursing metaparadigm with the main goals of improving health outcomes
and quality of life by decreasing the incidence of secondary cardiac death. Barriers to success
were addressed early in the implementation phase to create a plan of action when participants
discussed their vulnerabilities and lack of knowledge. A plan of action was prepared during the
counseling sessions for grocery shopping and eating out. This concept incorporated Pender’s
self-efficacy and health promotion initiation to overcome perceived barriers to action.
Interpersonal influences played an important role in the implementation and evaluation phase
due to the impact participant’s spouses, children, and friends. They encouraged health
promotion for participants and held participants accountable for committing to the plan of action,
as Pender suggested participants are more willing to follow through with the intervention with
the influence of a support system.
Strengths of Pender’s Health Promotion model are the concepts and application of
health promoting behavior within the nursing metaparadigm. The lifestyle modification program
was created within the context of nursing. The theory supports the purpose of this EBP project
to assist APNs with introducing and influencing health promoting behaviors based on literary
evidence. Preparation for working with participants with little or no self-efficacy skills and
understanding how to approach these patients with a treatment plan was guided by the Health
Promotion model. The main objectives focused on goal-setting; the project was six months in
duration in which small goals were implemented in the patient-guided booklet to meet the larger
overall goal of lowering or maintaining a therapeutic LDL-C level and healthy lifestyle choices.
Weaknesses of Pender’s Health Promotion model include the efforts of individualizing
treatment plans and how to guide patients of different cultural and socioeconomic backgrounds.
The majority of participants in this project were white, older adult males. Also, the complexity of
increasing participant access to resources and maintaining healthy lifestyles was difficult to
individualize based on participant’s geographical location. Participants may grow weary or
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complacent once they obtain a therapeutic LDL-C level and may not notice a difference in preand post- intervention behaviors. Bias occurs when an APN has personal choices that differ
from participants and may lead to a barrier. The Health Promotion model is patient-focused. For
example, choosing to participate in certain types of diets, fitness programs, and social media
sites is a personal preference and APNs must recognize their own preferences may differ from
patient preferences. The intervention was individualized, and therefore, time consuming due to
the complexity of considering participant appointment times, journaling during personal time,
and discussing status on the telephone. Overall, the Health Promotion model is an appropriate
nursing theory for this health-promoting nursing intervention.
EBP Framework
Stetler’s model for Research Utilization help guided the EBP process. The five phases of
this model include preparation, validation, decision-making, translation, and evaluation. This
model was an adequate fit for this EBP project based on the clinical need for lifestyle
modification guidance and motivation, which is first-line treatment, according to the ACC/AHA
guidelines. The literature search validated the need and effectiveness of lifestyle and healthcare
support. Also, relaying the information to participants in a relatable format appealed to their level
of knowledge and understanding, considering environmental factors. Goals were set based on
participant response to best practice recommendations. A final evaluation collectively assessed
objective and subjective findings from data collection for future practice.
The strengths and limitations of this EBP model included incorporating all five stages
from research utilization as a result of the literature review to an EBP intervention. The plan of
action was as step-by-step process that needed constant decision-making and translating into
nursing implications. Limitations included the inability to apply every assumption to the
participant’s situation. This project was the initial application of this EBP model by the project
manager and appropriate use could be a limitation. Modifications were made to simplify the
process to ease into the application of EBP. Although there were no major modifications, they
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involved taking a more subjective approach to relate the context of the material to achieve
targeted outcomes. The translation of research was based on a review of the literature and
implementing applicable interventions to patient population that included a validation of the
problem, after synthesizing the appraised literature.
Strengths and Limitations of the EBP Project
The strengths and weaknesses of this EBP project include what the outcomes implied,
such as medications are effective, and there is clinical significance for behavior changes toward
a heart healthy lifestyle, as validated through the initial literature search. Clinical use is practical,
increasing participant access to resources, cost-effective, and time efficient. This EBP project
applied national recommended guidelines as part of the literary synthesis into a translatable
intervention. The counseling portion took ten minutes to complete with the participant and
included focusing on each participant’s current lifestyle and preferences. Telephone calls
monitored participant progress and adherence to the lifestyle modification booklet. This booklet
was reviewed at the six-month follow-up. Participant’s growth of knowledge was evident through
verbalizing understanding of the material and applying the principles in their self-guided booklet.
By applying principles learned through the self-guided booklet, participants can be selfefficacious. Participants had completed the intervention which is supported by the significance
of the RYP for Blood Cholesterol tool and RAPA tool post-intervention scores. Overall, this EBP
project is patient-focused and provide means for lifestyle improvements without spending an
entire healthcare visit discussing lifestyle. This EBP project also supports self-learning and selfefficacy, based on the absence of attrition and completion of the self-guided booklet. Progress
can be measured through validated tools and evidence-based research that utilize nursing
theories and goals.
Weaknesses include: the overall sample size was small, which may influence the effect
size and applicability in larger samples, the participant population lacked diversity, so it is
unclear whether or not this intervention would be appropriate for various races/ethnicities,
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socioeconomic, marital, and/or gender groups. Participants had therapeutic LDL-C levels prior
to intervention, and there were no major changes in this post-intervention, so there was no
clinical significance regarding the reduction of LDL-C levels. This lifestyle modification
intervention may be more effective on patients who are at higher ASCVD risk and uncontrolled
cholesterol levels. The paper booklet may also be burdensome to some patients. Application of
this EBP project may vary in the future based on technological advances through smartphone
and computer usage.
Implications for the Future
Practice
Implications for advanced nursing practice are for the role of the family nurse practitioner
as clinician and consultant. By enforcing EBP and national guideline recommendations,
conclusions can be made to tailor a patient-centered counseling session and intervention to
improve clinical outcomes. The family nurse practitioner must consider the patient’s
environmental context in which health is maintained to assist in locating resources and support.
These environmental factors include patient’s culture, society, economics, and technology. The
FNP should act as change agents to modify current lifestyles. These environmental factors
impact patients in regard to their incomes, dietary budgets, physical limitations, access to
resources, computer and internet familiarity. The family nurse practitioner is a leader in regard
to change by initiating new ideas that are relevant in literature. Taking time to discuss patient’s
environment and self-efficacy toward health maintenance fulfills organizational goals to reduce
health disparities and costs of secondary cardiac events. These implications are applicable to all
three levels of prevention.
The lifestyle modification program can be applied to primary, secondary, and tertiary
levels of prevention for cardiac health. Primary prevention starts with preventing primary cardiac
events and promoting healthy lifestyles starting in adolescence and young adulthood through
education curriculums and well child visits. Secondary prevention occurs in patient follow-ups
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involving both the family nurse practitioner and the patient. The family nurse practitioner’s role
as clinician is to screen those with pertinent cardiac family history or ASCVD risk factors.
Tertiary prevention was implemented through this EBP project for those who had an initial
cardiac event and needed guidance to prevent a secondary cardiac event.
Theory
Pender’s Health Promotion model was an applicable nursing theory to assist the APN to
promote cardiac health in patients with established CAD. There is also a self-care deficit in
those patients who do not practice healthy lifestyles. Dorothy Orem’s Self-Care Deficit theory
which assesses a patient’s ability to care for self, and when there is a self-care deficit or patients
are “incapable of or limited in their ability to provide continuous effective care”, nurses need to
intervene (George, 2011, p. 117). Her theory could also be applied to this EBP project. Orem
explains five methods of helping that are relevant in health promoting interventions. They are
acting and doing for another, guiding and directing, providing physical or psychological support,
environmental support, and teaching. Educating patients must be relatable to their level of
knowledge and comprehension. This EBP project focused on patients with established CAD,
and the age group of the participant population consisted of mostly older adults, who preferred
writing on paper over typing on a computer. The learning material was taken from professional
literature, but created into a context that was understandable and relatable to the intended
population. Guiding and directing patients should be based on setting mutual goals, such as
reaching targeted LDL-C levels, making healthier dietary choices, and incorporating a physical
activity into their day, even small ones. This guidance should be focused on moving the patient
toward maintaining wellness on the healthcare continuum.
Furthermore, providing physical and psychological support was an essential component
for the desired outcomes and purpose of this EBP project. Connection should be kept open
between healthcare provider/project manager. This connection was achieved by reaching out to
participants during the implementation and monitoring phases through telephone calls, online
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support, and follow-up; resources from the AHA and NIH were also helpful to keep participants
on track. Teaching was applied during the initial counseling session with teachback methods.
Topics of discussion were the physiology of cholesterol, blood pressure, genetics, and weight to
correlate how each affects the role of health in the body. Nursing intervention depends on
patient preferences and response to their environment. Discharge or follow up to care happens
when participants are able to make lifestyle choices that impact longevity and quality of
cardiovascular health. Nursing actions should be based on patient response, to adapt and assist
patient where they’re at on the health continuum and move them toward wellness and evidencebased research that utilize nursing theories and goals, which is essential for Orem’s theory.
Research
Although this project was evidence-based, there are gaps in the literature regarding
further clinical investigation for adult patients with established CAD. New guidelines were
published from the ACC/AHA during the implementation process regarding the management of
blood cholesterol. With these new guidelines in place, further research should investigate the
percentage of LDL-C reduction in patients who are at higher risk for developing CAD or
experiencing a secondary cardiac event. A multidisciplinary, multifactorial intervention that
utilizes telehealth or electronic technology, such as smart phone applications may be beneficial
for those patients at risk for developing CAD or high ASCVD risk percentages. The use of
electronic technology and resources may provide better accountability due to programming
reminders and ease of downloading applications and typing into one central location to access a
variety of resources. Future research should be developed on the use of a multidisciplinary
team and relevant environmental resources to assist patients with healthier lifestyle choices on
a primary prevention level.
Education
Education impacts both the advanced practice and professional nurse. The family nurse
practitioner can further explore patient’s risk factors, current lifestyle choices, family history, and
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available options to discuss with patients during annual wellness or follow-up visits. Family
nurse practitioners are first line agents to advocate for lifestyle interventions at the
organizational level. This process calls for the practitioner to be a lifelong learner by constantly
reviewing newly released research and EBP and presenting the information to patients and
obtaining feedback to present to organizational administration for implementation. For the
professional nurse, the findings from this EBP project could be used to educate patients in the
clinical setting- either in a practice office or acute care setting. The significant role EBP plays in
the development of patient resources that promote cardiac care and how to access these
resources through a hospital organization. The professional nurse can also address the
immediate needs of the patient and modify the intervention based on the context of the patient’s
environment and access to resources. With education playing a role in EBP, nursing educators
can emphasize and teach the importance of professional nurses to educate patients and what
impacts their healthcare decisions. As well as the APN, who is the patient’s biggest advocate
and access to resources. Resources consist of providing local dieticians, lifestyle programs,
fitness activities, grocery store selection, and restaurants, as well as online support and groups.
Conclusion
In conclusion, the lifestyle prevention of secondary cardiac events would not only
decrease mortality worldwide, but also improve cardiac disparities and disease progression.
This EBP project addressed the clinical problem by lowering or maintaining therapeutic LDL-C
levels. The literary synthesize was supported by 16 pieces that emphasized a focus on altering
lifestyles; these literary pieces included systematic reviews, randomized control trials, literature
reviews, and clinical guidelines. Melynk and Fineout-Overholt (2015) was used to evaluate the
hierarchy of evidence, and the Johns Hopkins Nursing Research/Non-Research Evidence
Appraisal tool (2014) was used to appraise the evidence with guidance of the Stetler model for
EBP process and Nola Pender’s Health Promotion model. The overall best practice
recommendation was a multifactorial lifestyle modification program. An intervention was created
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from the literature which included counseling, education, LDL-C levels, BP, and BMI monitoring,
and dietary and physical activity assessment over six months. The clinical question was
answered and compelling findings included the significance of behavioral changes associated
with advocating and educating patients on a heart healthy lifestyle. Self-efficacy was apparent
through all the participants who completed the intervention. It was apparent through compliance
of completing the self-guided booklet, maintaining therapeutic LDL-C levels, and improvement in
dietary and physical activity scores. These inferences can be used as support for future
implications for nursing practice changes in the clinical setting, theory development, further
research, and education. This intervention can be used in clinical practice to prevent the
incidence of secondary and possibly primary cardiac events, reducing overall mortality of one of
the most fatal diseases.
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lifestyle
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American Heart
Association

Cole, Smith, Heart,
& Cupples (2011)
Systematic review
of the effect of diet
and exercise
lifestyle

“to determine
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effectiveness
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for the
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Design
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cohort study
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University
employees

Intervention:
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given by a
health-partner
on healthier
lifestyles on CV
risk factors
(AHA Life’s
Simple 7)
Participants
given
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regarding diet
and physical
activity
Systematic
review pf 21
RCTs; metaanalysis with
95% CI
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over 2 yearsbaseline, 6months, 1year, and 2years

n = 10,799
Adults ages
18 years or
older

Measurement/
Outcomes

Results/Findings

Physical
measurements:
vital signs,
height/weight,
and waist hip ratio

Decrease in SBP and DBP at 6
months (-3.6 mmHg and -2.2
mmHg, p<0.0001)

Level/
Qualit
y
IV, A

Improvement in LDL-C
(p<0.001)

Lipid panel
Metabolic panel

Physical activity increased by
6% at 6 months(P=0.04)
Dietary changes improved,
scores increased by 0.46 with
baseline poor diet scores at 6
months (P<0.001)

Primary
outcomes:
All-cause
mortality, cardiac
mortality, nonfatal
cardiac events,

Diet: 39 out of 51 outcomes
were significant in dietary
improvement to include
improvement for intake of fiber,
fat, sugar, and cholesterol

I, A
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interventions in the
secondary
prevention of
coronary heart
disease

prevention of
coronary
heart
disease”
(Cole et al.,
2011, p. 2)

Cardiology
Research and
Practice

de Waure et al.
(2013)
Lifestyle
interventions in
patients with
coronary heart
disease: A
systematic review
American Journal of
Preventive Medicine

Setting:
outpatient
clinical setting
or home-based
interventions
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Duration: 3
months to 5
years with
follow-up
every 3
months

Interventions:
dietary,
exercise,
psychological,
educational,
multifactorial,
organizational

Reduce risk
for fatal and
nonfatal CV
events with
established
CHD

Systematic
review of 14
RCTs; metaanalysis, groups
compared with
RR, 95% CI
Setting:
Telephonebased,
outpatient
setting, or home
Intervention:
Multifactorial
lifestyle
components

n = 6,657
Patients with
established
CHD
Duration: at
least 6
months

hospital
admissions
Secondary
outcomes:
Diet (intake of
fiber, fruits, &
vegetables),
exercise, blood
pressure, blood
lipid levels, health
related quality of
life, self- efficacy,
and medication
adherence
Primary
outcomes: fatal
and nonfatal CV
events (MI,
revascularization,
and death)
Secondary
outcomes: overall
mortality and
hospital
readmissions

Physical Activity: 20 studies
showed significant
improvements in workload
Blood pressure: 5 out of 13
studies reported benefits at 3
months and 12 months
LDL-C: 5 studies reported
significant improvements
Self-efficacy: reported in 1
study, significant improvement
in self-management at 6-month
follow-up
Multifactorial lifestyle
interventions should be
considered in secondary
prevention programs
Reduced fatal CV events with
estimated RR 18%; (RR= 0.82,
95% CI = 0.69, p = 0.003)
Reduced overall mortality; RR
0.94, 95% CI = 0.83, 1.06; p =
0.32)
Improvement in risk factors for
home-based interventions:
Decrease in SBP WMD (-4.36
mmHg, 95% CI = -6.50, -2.22)

I, A

LIFESTYLE MODIFICATION PROGRAM

Drakopoulou et al.
(2016)
Managing lipid
profile of coronary
heart disease
patients
Expert Review of
Cardiovascular
Therapy

“summary of
current
recommendat
ions for lipid
profile
management
in patient with
CHD, with
view to
present
lifestyle
modification
and novel
treatment
strategies
indicating
also the
areas of
dispute
between
recent
guidelines”
(Drakopoulou

(reducing blood
pressure, LDLC, blood
glucose,
smoking,
physical activity,
stress, and
weight) and
patient-tailored
Expert opinion
on the
guidelines
established by
the ACC/AHA
and European
Society
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Total cholesterol WMD (-0.33,
95% CI= -0.57, -0.08)

Lifestyle and
treatment
therapies for
patients with
coronary
heart disease

Focus on lipid
levels, blood
pressure,
European Society
recommends
adding behavioral
and psychosocial
risk factors,
smoking
cessation, and
body weight
control

Increase vegetable, fiber,
whole grains, low-fat dairy,
poultry, legumes, fish, and nuts
for dietary improvements
Stress the importance of daily
exercise (reduces LDL-C by 36 mg/dL when performed for 24
weeks in duration, greater than
3 days per week for 40
minutes)
Obtain secondary lipid panel at
4-12 weeks after initiation of
statin therapy or change in
therapy to further determine
patient’s adherence (then
perform every 3-12 months)
No emphasized LDL-C target
goals

VII, B
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Eckel et al. (2014)
2013 AHA/ACC
guideline on lifestyle
management to
reduce
cardiovascular risk
Journal of the
American College of
Cardiology

Hooper, Martin,
Abdelhamid, &
Smith (2015)
Reduction in
saturated fat intake

et al., 2016,
p. 1263)
“prevent
CVDs,
improve
management
of people
who have
these
diseases
through
professional
education
and research;
and develop
guidelines
and
standards
and policies
that promote
optimal
patient care
and CV
health” (Eckel
et al., 2014,
p. 2961)
Discover the
effects on
health of
cutting down
on saturated
fat intake

Expert Work
Group with 16
members
(expert panel)
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For patients
who are at
risk or have
CVD

Guideline
developed that
includes data
from RCTs,
observational
studies,
systematic
reviews with
meta-analysis

Systematic
review; metaanalysis with
RR for
dichotomous
data and MD for
continuous data

Effects on total
cholesterol, LDLC, blood
pressure, levels
of aerobic activity,
and dietary habits

Emphasized focus on low fat
dietary patterns (decrease in
fats- as a macronutrient, i.e.
DASH diet, Mediterranean diet)

VII, A

Dose dependent inverse
relationship between levels of
physical activity and rates of
CVD and beneficial effects on
lipids, cholesterol, and blood
pressure
10 Lifestyle recommendations
(p. 2968- 2970)

15 RCTS
n = 759,000
Adults with or
at risk for
CVD

Primary
outcomes:
All-cause
mortality, CVD
mortality, CVD
events

No clear effects on all cause or
CVD mortality
13% reduction in CHD events
(RR 0.87, 95% CI 0.74 to 1.03)

I, B
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for cardiovascular
disease

Intervention:
modified fat
diets compared
with usual diets

Cochrane Database
of Systematic
Reviews

Kotseva et al.
(2016)
Euroaspire IV: A
European Society of
Cardiology survey
on the lifestyle, risk
factor and
therapeutic
management of
coronary patients
from twenty-four
European countries
European Journal of
Preventive
Cardiology

Identify
patient risk
factors,
describe
management
through
lifestyle and
drug
therapies,
and provide
objective
assessment
of clinical
implementati
on of current
scientific
knowledge

Cross-sectional
study
Collected data:
Medical records
and interviews
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Duration: at
least 2 years

n = 16,426
medical
records
reviewed
n = 7,998
patients
interviewed
Patients < 80
years old with
CD who had
CABG, PCI,
or ACS
Duration: 6
months

Secondary
outcomes:
Fatal and nonfatal cardiac
events, blood
lipids, cancer,
blood pressure,
BMI, body weight,
and quality of life

LDL-C sig. reduction (MD -0.19
mmol/L, 95% CI -0.33 to -0.05)
Significant reduction in SBP
(MD -0.19 mmHg, 95% CI -1.36
to -0.97) and DBP (MD -0.36
mmHg, 95% CI -1.03 to 0.32)

Physical activity

Significant difference in BMI
(MD -0.50, 95% CI, -0.82 to 0.19)
Physical activity increased by
followed advice from a health
or exercise professional
(23.5%), attended a gym or
exercise program (52.8%)
Increased daily physical activity
(17.4%)

Waist
circumference

Knowledge of weight (93.4%)
and blood pressure (86.7%)

Blood pressure

Unaware of cholesterol (48.9%)
and waist circumference
(29.3%)

Lifestyle risk
factors and
therapeutic
targeted
measures

LDL-C
Smoking habits
Cardioprotective
medications
Diabetes

Patients on lipid lowering
medications (86.6%), mainly
statins (85.7%)

VI, A
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Noe, Dosa, Ranky,
& Pavlik (2014)
Cardiovascular
results of an
individually
controlled complex
prevention
Acta Physiologica
Hungarica

“To study the
effect of a sixmonth regular
training
program of
two different
intensities on
patients with
previously
existing risk
factors (Noe
et al., 2014,
p. 2)

Quasiexperimental
Patients
followed lifestyle
modification and
nutrition and
separated into 3
groups for
training
sessions
Group A:
combined
(aerobic and
resistance)
training
sessions four
times per week
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n = 75
patients with
risk factors
3 groups
A & B n = 50

Cardiac rehab
attendance
Blood pressure
Heart rate
Lipid profile
BMI

C n = 25
Exercise tests
Duration: 6
months

BMI significantly decreased:
Group A > Group B (8.7%
versus 5.0%)

III, A

Reduction in BP:
Group A resting SBP and DBP
decreased by (8.5% and 7.0%,
respectively)
Group B reduction was smaller
(5.5% and 4.7%)
LDL-C decreased (Group A
29.8% vs Group B 21.2%)

Group B: 2-3
times per week

Rees et al. (2013)
Dietary advice for
reducing
cardiovascular risk
(review)

Group C: no
regular physical
activity
Addresses
Systematic
the effect of
review of 44
dietary advice RCTs; metaamong
analysis with
healthy
95% CI
people to

n = 18,175
Healthy
adults with
cardiovascula
r risk factors

Primary
outcomes: CV
risk factors, blood
pressure, lipids,
and biomarkers of
dietary intake

Blood pressure was reported in
11 studies; SBP reduced by
I, A
2.61 mmHg (-2.61, 95% CI 3.91 to – 1.31) DBP reduced by
1.45 mmHg (-1.45, 95% CI 2.22 to – 0.68)

LIFESTYLE MODIFICATION PROGRAM

Cochrane Database
of Systematic
Reviews

Rippe &
Angelopoulous
(2014)
Lifestyle strategies
for cardiovascular
risk reduction
Current
Atherosclerotic
Report

establish
relevance in
clinical
practice

Summarize
recent
literature
review to how
specific
lifestyles
strategies
may be
employed to
lower risk of
CV disease

Setting: Clinical
healthcare
Interventions:
verbal or written
advice delivered
in person

Literature
review on the
AHA Strategic
Plan for 2020
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Duration: 3
months to 12
months

Patients who
have or at
risk for CVDs

Secondary
outcomes: selfreported dietary
intake

Lipids reported in 18 studies:
small but significant reduction
in total cholesterol 0.15 mmol/L
(difference means -0.15, 95%
CI -0.23 to – 0.06)
LDL-C reduced in 13 studies;
0.16 mmol/L (-0.16, 95% CI 0.24 to -0.08)

DASH diet resulted in largest
reduction of fat intake of
10.9%; saturated fat reduced
by 2.39% (-2.39, 95% CI -3.37
to – 1.4)
Discuss BMI
Overall, counseling patients
VII, B
(weight), amount
that lifestyle changes can
of physical activity produce modest to sustained
per week, blood
weight loss and achieve
pressure, dietary
meaningful health benefits,
type/patterns, and thus reducing CV risk
smoking habits
DASH diet adherence improves
CV health
Physical activity
recommendation of 3-4
sessions of physical activity at
40 minutes per session of
moderate to intense aerobic
and resistance exercise

LIFESTYLE MODIFICATION PROGRAM
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Discontinue targeted treatment
LDL goals; 4 major statin
benefit groups

Salehi- Abargouei et “. . .
al. (2013)
summarize
the
Effects of Dietary
information
Approaches to Stop and assess
Hypertension
the
(DASH)- style diet
magnitude of
on fatal or nonfatal
the relation
cardiovascular
between
disease- Incidence: imitating a
A systematic review DASH-style
and meta-analysis
diet and
on observational
CVDs or its
prospective studies major
subclass like
Nutrition
CHD, stroke,
and HF in
prospective
cohorts”
(SalehiAbargouei et
al., 2013, p.
612)

Systematic
review; metaanalysis
using calculated
RR and its SE,
with 95% CI,
P <0.05
6 cohort studies
Intervention:
Imitating DASH
style diet

n = 260,011
Adults with or
at risk for
CVD

Incidence of
CVDs, CHD, or
stroke

JNC 8 recommendations of
regular aerobic exercise,
limiting salt, maintain a healthy
body weight, and smoking
cessation for blood pressure
management
3 out of the 6 studies included
data in relation to CHD
In 144, 337 adults eating DASH
diet can lower risk for CHD
(RR 0.79, 95% CI, 0.71-0.88, P
<0.001)
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VII, A
Stone et al. (2014)
2013 ACC/AHA
guidelines on the
treatment of blood
cholesterol to
reduce
atherosclerotic
cardiovascular risk
in adults
Journal of the
American College of
Cardiology
Stuart et al. (2013)
A telephonesupported
cardiovascular
lifestyle programme
(CLIP) for lipid
reduction and
weight loss in
general practice
patients: A
randomised
controlled pilot trial
Public Health
Nutrition

“define
practices that
meet the
needs of
patients in
most
circumstance
s . . .” (Stone
et al., 2014,
p. 2891)

Expert panel
(16 members)

“. . . evaluate
a primary
prevention
care model
using
telephone
support”
(Stuart et al.,
2013, p. 641)

RCT pilot trial

NHLBI
systematic
evidence review
which consists
of RCTs,
systematic
reviews with
meta-analysis of
RCTs

Intervention:
handbook with
dietary meal
plans, recipes,
and physical
activity plans
and telephone
based coaching
sessions
Control: usual
care and
general lifestyle
handouts

Intended for
Blood cholesterol
the treatment panel
of adults ages
21 years or
older to
complement
the NHLBI
CV health
risk-reduction
guidelines

Lifestyle is the foundation for
ASCVD risk factors

Intervention
(CLIP) n = 26

LDL-C

No changes in BP or
cholesterol meds over course
of study

Control
n = 23

Waist
circumference

Duration: 12
weeks

Blood pressure
Physical activity
Motivation

Recommended guideline:
4 major statin benefit groups
p.2897
No specific targeted LDL-C
goal
Secondary prevention- high
intensity therapy most
beneficial for patients less than
or equal to 75 years of age

CLIP participants demonstrated
significantly greater reductions
in LDL-C with significant main
effect for treatment on LDL-C
(F (1,43) = 15.50, P = 0.001)
No significant effect on blood
pressure- stable throughout
study
systolic (F (1, 45) = 0.28, P =
0.60) or diastolic (F(1, 43) =
0.52, P = 0.47)
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Tapsell & Neale
(2016)
The effect of
interdisciplinary
interventions on risk
factors for lifestyle
disease: A literature
review
Health Education
and Behavior

“Examine
evidence of
interdisciplina
ry
interventions
on lifestyle
disease risk
factors
including
weight, lipid
level,
glycemic
control, and
blood
pressure to
summarize
the
characteristic
features of
successful
interventions”
(Tapsell &
Neale, 2016,
p. 272)

Systematic
review; metasynthesis
16 studies
RCTs= 7
Pseudorandomi
zed(not truly)= 3
Pre &Post test
results without
comparisons to
a control group
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n = 15,890
adults with
chronic
disease

Weight

CLIP participants experienced
weight loss but not significant,
no significant treatment effect
on waist circumference;
however, positive correlation
between weight loss and LDLC (r = 0.560, n 26, P = 0.003)
1 of 6 studies found greater
improvements in blood lipids

Lipid levels
Hemoglobin A1c
Blood pressure
Characteristic
features of
successful
interventions

5 studies found reductions in
blood pressure
Greater effects seen where
there was a greater amount of
contact between health
professionals and participants
The addition of exercise and/or
behavior modifications to
dietary advice resulted in
significant reductions in body
weight and improvements in
blood pressure
Weekly contact produced
positive outcomes- ongoing

V, C
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van den Wijngaart,
Sieben, van der
Vlugt, de LeeuW, &
Bredie (2015)
A nurse-led
multidisciplinary
intervention to
improve
cardiovascular
disease profile of
patients
Western Journal of
Nursing Research

“. . . evaluate
the
magnitude of
change in
various
modifiable
cardiovascula
r risk factors,
such as body
mass index,
waist, blood
pressure,
lipid levels,
and lifestyle
parameters,
during shortand long-term
follow-up”
(van den
Wijngaart,
2015, p. 707)

Quasiexperimental
- one treatment
group
Intervention:
Evaluation of
risk profile and
individualized
treatment plan
was
implemented,
including both
pharmacological
and lifestyle
behavior
change

87
n = 176

Baseline
characteristics:
Patients with age, gender, BP,
CVD
BMI, LDL-C, waist
circumference,
Setting:
smoking habits,
outpatient
alcohol usage,
clinical setting and eating habits

Duration: 3 15 months;
LDL-C, BMI,
and BP were
monitored at
3 and 6
months

Differences
measured by
univariate
ANOVA
Effect of
intervention
measured by
paired t - test or
chi-squared

Significant reduction in SBP
(138.3  20.7 mmHg to 128.7 
17.7 mmHg;
p <0.01)
Significant reduction in LDL-C
(2.55  0.87 mmol/L to 2.16 
0.73 mmol/L;
p <0.01)
Less patients became physical
activity toward end of study
BMI increased from 26.6  4.5
to 27.5
 4.8 kg/m2
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Appendix B

Rate-Your-Plate for Blood Cholesterol (RYP) tool
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Appendix B (continued)
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Appendix B (Continued)
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Appendix C

Rapid Assessment of Physical Activity (RAPA) tool

LIFESTYLE MODIFICATION PROGRAM

93

LIFESTYLE MODIFICATION PROGRAM

94

LIFESTYLE MODIFICATION PROGRAM

95

